Tp53 (tumor protein p53) - Rat Genome Database

Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)
Gene: Tp53 (tumor protein p53) Rattus norvegicus
Analyze
Symbol: Tp53
Name: tumor protein p53
RGD ID: 3889
Description: Enables several functions, including MDM2/MDM4 family protein binding activity; transmembrane transporter binding activity; and ubiquitin protein ligase binding activity. Involved in several processes, including cellular response to polyamine macromolecule; regulation of apoptotic process; and regulation of macromolecule biosynthetic process. Located in PML body and chromatin. Part of RNA polymerase II transcription regulator complex. Used to study disease of cellular proliferation (multiple); oral mucosa leukoplakia; and traumatic brain injury. Biomarker of several diseases, including bronchopulmonary dysplasia; gastrointestinal system cancer (multiple); ischemia; oral mucosa leukoplakia; and vascular dementia. Human ortholog(s) of this gene implicated in several diseases, including Li-Fraumeni syndrome (multiple); carcinoma (multiple); hematologic cancer (multiple); open-angle glaucoma (multiple); and pancreatic cancer (multiple). Orthologous to human TP53 (tumor protein p53); PARTICIPATES IN altered p53 signaling pathway; endometrial cancer pathway; non-small cell lung carcinoma pathway; INTERACTS WITH (+)-catechin; (+)-dexrazoxane; (+)-schisandrin B.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: cellular tumor antigen p53; MGC112612; p53; transformation related protein 53; Trp53; tumor protein p53 (Li-Fraumeni syndrome); tumor suppressor p53
RGD Orthologs
Human
Mouse
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Orthologs
More Info more info ...
Related Pseudogenes: Tp53-ps1   Tp53-ps3  
Allele / Splice: Tp53em3Mcwi ; Tp53m1Kyo ; Tp53tm1(EGFP-Pac)Qly ; Tp53em1Sage
Genetic Models: SD-Tp53em3Mcwi ; SD-Tp53em1Sage ; STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc ; F344-Tp53m1Kyo
Is Marker For: Strains:   STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc   F344-Tp53m1Kyo  
Candidate Gene For: Hcar1
Latest Assembly: GRCr8 - GRCr8 Assembly
Position:
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81054,798,871 - 54,810,300 (+)NCBIGRCr8
mRatBN7.21054,300,070 - 54,311,525 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1054,300,048 - 54,311,524 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1058,962,496 - 58,973,951 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01058,451,039 - 58,462,496 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01053,958,739 - 53,970,151 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01056,186,299 - 56,198,449 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1056,187,020 - 56,198,449 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01055,932,658 - 55,944,087 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41056,399,721 - 56,411,150 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11056,413,290 - 56,424,751 (+)NCBI
Celera1053,454,375 - 53,465,803 (+)NCBICelera
Cytogenetic Map10q24NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
Acute Erythroleukemia  (ISO)
acute kidney failure  (ISO)
acute lymphoblastic leukemia  (ISO)
acute megakaryocytic leukemia  (ISO)
acute myeloid leukemia  (ISO)
adenocarcinoma  (ISO)
adenoid cystic carcinoma  (ISO)
adenoma  (ISO)
Adrenal Cortex Neoplasms  (ISO)
Adrenal Gland Neoplasms  (ISO)
adrenocortical carcinoma  (ISO)
adult T-cell leukemia/lymphoma  (ISO)
Alzheimer's disease  (ISO)
amyotrophic lateral sclerosis  (ISO)
anaplastic astrocytoma  (ISO)
anaplastic thyroid carcinoma  (ISO)
angiosarcoma  (ISO)
Animal Disease Models  (ISO)
Arsenic Poisoning  (ISO)
atherosclerosis  (ISO)
atypical teratoid rhabdoid tumor  (ISO)
Autosomal Recessive Dyskeratosis Congenita  (ISO)
autosomal recessive dyskeratosis congenita 3  (ISO)
B-Cell Chronic Lymphocytic Leukemia  (ISO)
B-lymphoblastic leukemia/lymphoma  (ISO)
Balkan nephropathy  (ISO)
basal cell carcinoma  (ISO)
bone development disease  (ISO)
Bone Marrow Failure Syndrome 5  (ISO)
Bone Marrow Neoplasms  (ISO)
bone osteosarcoma  (ISO)
brain ischemia  (ISO)
Brain Neoplasms  (ISO)
breast adenocarcinoma  (ISO)
breast cancer  (ISO,ISS)
Breast Cancer, Familial  (ISO)
breast carcinoma  (ISO)
Breast Neoplasms  (ISO)
bronchiolo-alveolar adenocarcinoma  (IMP)
bronchopulmonary dysplasia  (IEP)
Calcification of Aortic Valve  (ISO)
calcinosis  (ISO)
carcinoma  (ISO)
cardiomyopathy  (ISO)
Cardiotoxicity  (ISO)
carotid artery disease  (ISO)
cataract  (ISO)
Cecal Neoplasms  (ISO)
Central Nervous System Neoplasms  (ISO)
cervical adenocarcinoma  (ISO)
cervical cancer  (ISO)
cervical squamous cell carcinoma  (ISO)
CHARGE syndrome  (ISS)
Chemotherapy-Induced Febrile Neutropenia  (ISO)
cholangiocarcinoma  (ISO)
cholesteatoma of middle ear  (ISO)
choroid plexus carcinoma  (ISO)
choroid plexus papilloma  (ISO)
Chromosome 17 Deletion  (ISO)
chronic lymphocytic leukemia  (ISO)
chronic obstructive pulmonary disease  (ISO)
clear cell adenocarcinoma  (ISO)
clear cell renal cell carcinoma  (ISO)
Cognitive Dysfunction  (ISO)
colon carcinoma  (ISO)
Colon Diverticulum  (ISO)
Colonic Neoplasms  (ISO)
colorectal adenocarcinoma  (ISO)
colorectal cancer  (IEP,ISO)
colorectal carcinoma  (ISO)
Colorectal Neoplasms  (ISO)
common variable immunodeficiency  (ISO)
congenital fibrosarcoma  (ISO)
congenital merosin-deficient muscular dystrophy 1A  (ISO)
congenital myasthenic syndrome 2A  (ISO)
congestive heart failure  (ISO)
coronary artery disease  (ISO)
coronary restenosis  (ISO)
Craniofacial Abnormalities  (ISO)
demyelinating disease  (ISO)
Diabetic Nephropathies  (IEP)
Diamond-Blackfan anemia  (ISO)
diffuse large B-cell lymphoma  (ISO,ISS)
diffuse pediatric-type high-grade glioma, H3-wildtype and IDH-wildtype  (ISO)
DiGeorge syndrome  (ISO)
dilated cardiomyopathy  (IEP)
disease of cellular proliferation  (IMP,ISO)
Disease Progression  (ISO)
Drug-induced Neutropenia  (ISO)
Drug-Related Side Effects and Adverse Reactions  (ISO)
Ductal Carcinoma  (ISO)
ductal carcinoma in situ  (ISO)
Dwarfism  (ISO)
dyskeratosis congenita  (ISO,ISS)
Emphysema  (ISO)
endometrial adenocarcinoma  (ISO)
endometrial cancer  (ISS)
endometrial carcinoma  (IMP,ISO)
Endometrial Intraepithelial Neoplasia  (ISO)
Endometrial Neoplasms  (ISO)
esophageal cancer  (ISO)
esophageal carcinoma  (ISO)
Esophageal Neoplasms  (IEP,ISO)
esophagus adenocarcinoma  (ISO)
esophagus squamous cell carcinoma  (ISO)
Experimental Diabetes Mellitus  (IEP,ISO)
Experimental Liver Neoplasms  (ISO)
Experimental Mammary Neoplasms  (IEP,ISO)
Experimental Neoplasms  (ISO)
Eye Neoplasms  (ISO)
familial melanoma  (ISO)
Familial Pancreatic Carcinoma  (ISO)
Female Infertility  (ISO)
Funnel Chest  (ISO)
gallbladder cancer  (ISO)
Gallbladder Neoplasms  (ISO)
gastric adenocarcinoma  (ISO)
glioblastoma  (ISO,ISS)
graft-versus-host disease  (ISO)
Graves' disease  (ISO)
head and neck squamous cell carcinoma  (ISO)
hematologic cancer  (ISO)
hepatoblastoma  (ISO)
hepatocellular carcinoma  (IEP,ISO)
Hereditary Adrenocortical Carcinoma  (ISO)
hereditary breast ovarian cancer syndrome  (ISO)
Hereditary Neoplastic Syndromes  (ISO)
high grade glioma  (ISO)
hypertension  (ISO)
hypertrophic cardiomyopathy  (ISO)
Hypogonadism and Testicular Atrophy  (IMP)
ischemia  (IEP,ISO)
Kaposi's sarcoma  (ISO)
keratosis  (ISO)
Leber hereditary optic neuropathy  (ISO)
leukemia  (ISO)
Li-Fraumeni syndrome  (ISO,ISS)
Li-Fraumeni syndrome 1  (ISO)
Li-Fraumeni-Like Syndrome  (ISO)
Lip Neoplasms  (ISO)
Liver Neoplasms  (ISO)
low tension glaucoma  (ISO)
lung adenocarcinoma  (ISO)
Lung Neoplasms  (IMP,ISO)
lung non-small cell carcinoma  (ISO)
lung sarcomatoid carcinoma  (ISO)
lung small cell carcinoma  (ISO)
lung squamous cell carcinoma  (ISO)
Lymphatic Metastasis  (ISO)
lymphoma  (ISO)
male infertility  (ISO)
malignant astrocytoma  (ISO)
malignant mesothelioma  (ISO)
marginal zone lymphoma  (ISO)
medulloblastoma  (ISO)
melanoma  (ISO)
meninges sarcoma  (IMP)
Mesothelioma  (ISO)
mismatch repair cancer syndrome  (ISO)
mitochondrial metabolism disease  (ISO)
Mouth Neoplasms  (IEP,ISO)
multiple myeloma  (ISO)
myelodysplastic syndrome  (ISO)
myelofibrosis  (ISO)
myeloid leukemia associated with Down Syndrome  (ISO)
myeloid neoplasm  (ISO)
myocardial infarction  (ISO)
Myocardial Reperfusion Injury  (IEP)
nasal cavity cancer  (ISO)
Nasopharyngeal Neoplasms  (ISO)
nasopharynx carcinoma  (ISO)
Neoplasm Metastasis  (IMP,ISO)
Neoplastic Cell Transformation  (ISO)
nephroblastoma  (ISO)
Nerve Sheath Neoplasms  (ISO)
nervous system disease  (ISO)
neuroblastoma  (ISO)
non-Hodgkin lymphoma  (ISO)
Odontogenic Myxoma  (ISO)
Oral Lichen Planus  (ISO)
oral mucosa leukoplakia  (IEP,IMP,ISO)
oral squamous cell carcinoma  (ISO)
oral submucous fibrosis  (ISO)
Oropharyngeal Neoplasms  (ISO)
osteosarcoma  (IMP,ISO,ISS)
ovarian cancer  (ISO)
ovarian carcinoma  (ISO)
Ovarian Neoplasms  (ISO)
ovarian small cell carcinoma  (ISO)
ovary serous adenocarcinoma  (ISO)
pancreatic cancer  (ISO)
pancreatic carcinoma  (ISO)
pancreatic ductal carcinoma  (ISO)
pancreatic intraductal papillary-mucinous neoplasm  (ISO)
pancytopenia  (ISO)
papillary thyroid carcinoma  (ISO)
paranasal sinus benign neoplasm  (ISO)
Paraproteinemias  (ISO)
Parasitic Liver Diseases  (ISO)
Pediatric Adrenocortical Carcinoma  (ISO)
Penile Neoplasms  (ISO)
Phyllodes Tumor  (ISO)
plasma cell neoplasm  (ISO)
pleomorphic xanthoastrocytoma  (ISO)
Pleural Effusion  (ISO)
Polyploidy  (ISO)
pre-malignant neoplasm  (IEP,ISO)
Premature Aging  (ISO)
primary cutaneous T-cell non-Hodgkin lymphoma  (ISO)
primary open angle glaucoma  (ISO)
prostate adenocarcinoma  (ISO)
prostate cancer  (ISO)
Prostate Cancer, Hereditary, 1  (ISO)
Prostatic Neoplasms  (ISO)
psoriasis  (ISO)
pterygium  (ISO)
pulmonary hypertension  (ISO)
renal cell carcinoma  (ISO)
Reperfusion Injury  (IEP)
rhabdomyosarcoma  (ISO)
SAPHO syndrome  (ISO)
sarcoma  (IMP,ISO)
schizophrenia  (ISO)
serous cystadenocarcinoma  (ISO)
Sezary's disease  (ISO)
skin melanoma  (ISO)
Skin Neoplasms  (ISO)
small cell carcinoma  (ISO)
Spinal Cord Injuries  (IEP)
spondyloarthropathy  (ISO)
squamous cell carcinoma  (ISO)
stomach cancer  (ISO)
Stomach Neoplasms  (ISO)
T-cell non-Hodgkin lymphoma  (ISO)
thymoma  (ISO)
Thymus Neoplasms  (ISO)
Thyroid Neoplasms  (ISO)
Tongue Neoplasms  (IEP,IMP,ISO)
tongue squamous cell carcinoma  (IEP)
transitional cell carcinoma  (ISO)
transthyretin amyloidosis  (ISO)
traumatic brain injury  (IMP)
Trigeminal Nerve Injuries  (IEP)
ulcerative colitis  (ISO)
urinary bladder cancer  (ISO)
Urinary Bladder Neoplasm  (ISO)
Urogenital Neoplasms  (ISO)
Urologic Neoplasms  (ISO)
vascular dementia  (IEP)
very long chain acyl-CoA dehydrogenase deficiency  (ISO)
Vulvar Lichen Sclerosus  (ISO)
Vulvar Neoplasms  (IEP,ISO)
xeroderma pigmentosum  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-(S)-ar-turmerone  (ISO)
(+)-artemisinin  (ISO)
(+)-catechin  (EXP,ISO)
(+)-dexrazoxane  (EXP,ISO)
(+)-epicatechin-3-O-gallate  (ISO)
(+)-schisandrin B  (EXP,ISO)
(-)-alpha-phellandrene  (ISO)
(-)-anisomycin  (EXP)
(-)-citrinin  (EXP,ISO)
(-)-epigallocatechin 3-gallate  (EXP,ISO)
(-)-noscapine  (ISO)
(1->4)-beta-D-glucan  (ISO)
(1S)-bornane-2,3-dione  (ISO)
(20R)-protopanaxadiol  (ISO)
(6aR,11aS,11bR)-10-acetyl-11-hydroxy-7,7-dimethyl-2,6,6a,7,11a,11b-hexahydro-9H-pyrrolo[1',2':2,3]isoindolo[4,5,6-cd]indol-9-one  (ISO)
(9E,11E)-octadecadienoic acid  (ISO)
(aminomethyl)phosphonic acid  (ISO)
(R)-adrenaline  (ISO)
(R)-lipoic acid  (EXP)
(R)-noradrenaline  (EXP)
(R,R,R)-alpha-tocopherol  (ISO)
(S)-colchicine  (ISO)
(S)-naringenin  (ISO)
(S)-nicotine  (EXP,ISO)
(S)-ropivacaine  (EXP)
(Z)-3-butylidenephthalide  (ISO)
(Z)-ligustilide  (ISO)
1'-acetoxychavicol acetate  (ISO)
1,1'-azobis(N,N-dimethylformamide)  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (EXP)
1,1-dichloroethene  (ISO)
1,10-phenanthroline  (ISO)
1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene  (ISO)
1,2-dichloroethane  (ISO)
1,2-dimethylhydrazine  (EXP,ISO)
1,3-Dinitropyrene  (ISO)
1,4-benzoquinone  (ISO)
1,4-dithiothreitol  (ISO)
1,8-Dinitropyrene  (ISO)
1-[(2,3,4-trimethoxyphenyl)methyl]piperazine  (ISO)
1-hydroxy-1-norresistomycin  (ISO)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine  (ISO)
1-methylphenanthrene  (EXP)
1-naphthyl isothiocyanate  (EXP)
1-nitropyrene  (EXP,ISO)
11-deoxycorticosterone  (EXP)
17alpha-ethynylestradiol  (EXP,ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (EXP)
17beta-hydroxy-17-methylestra-4,9,11-trien-3-one  (ISO)
19-Nor-17alpha-pregn-5(10)-en-20-yne-3alpha,17beta-diol  (EXP)
1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one  (ISO)
1H-pyrazole  (ISO)
2'-Hydroxy-2,3,5'-trimethoxychalcone  (ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP,ISO)
2,2',5,5'-Tetrachlorobenzidine  (ISO)
2,2',5,5'-tetrachlorobiphenyl  (ISO)
2,2'-dithiodiethanol  (ISO)
2,2,2-tetramine  (ISO)
2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one  (ISO)
2,3,4,6-tetrachlorophenol  (ISO)
2,3,5,6-tetrachlorophenol  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,4,4'-trichlorobiphenyl  (ISO)
2,4,6-trinitrobenzenesulfonic acid  (EXP,ISO)
2,4-D  (EXP,ISO)
2,4-dibromophenol  (ISO)
2,4-dinitrotoluene  (EXP)
2,6-di-tert-butyl-4-methylphenol  (EXP)
2,6-dichloroindophenol  (ISO)
2,6-dinitrotoluene  (EXP)
2-acetamidofluorene  (EXP,ISO)
2-amino-4,6-dinitrotoluene  (ISO)
2-deoxy-D-glucose  (ISO)
2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid  (ISO)
2-methoxyethanol  (EXP)
2-naphthylamine  (ISO)
2-nitropropane  (ISO)
2-nitrotoluene  (ISO)
2-pyridylethylamine  (ISO)
2-tert-butylhydroquinone  (EXP,ISO)
25-hydroxycholesterol  (ISO)
3',4',7-trihydroxyisoflavone  (ISO)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (EXP,ISO)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5,5'-tetrabromobisphenol A  (EXP,ISO)
3,3',5,5'-tetraiodothyroacetic acid  (EXP,ISO)
3,3'-Dichlorobenzidine  (ISO)
3,3'-diindolylmethane  (ISO)
3,4,8-Trimethyl-1H,2H,3H-imidazo[4,5-F]quinoxalin-2-imine  (ISO)
3,6-diaminoacridine  (ISO)
3,7-dihydropurine-6-thione  (ISO)
3-\{1-[3-(dimethylamino)propyl]-1H-indol-3-yl\}-4-(1H-indol-3-yl)-1H-pyrrole-2,5-dione  (ISO)
3-aminobenzamide  (ISO)
3-BROMO-7-NITROINDAZOLE  (ISO)
3-bromopyruvic acid  (ISO)
3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone  (EXP)
3-chloropropane-1,2-diol  (ISO)
3-hydroxybutyric acid  (ISO)
3-iodoprop-2-yn-1-yl butylcarbamate  (ISO)
3-methyladenine  (ISO)
3-methylcholanthrene  (EXP,ISO)
3-methylfuran  (EXP)
3-Nitrobenzanthrone  (ISO)
3-Nitrofluoranthene  (ISO)
3-phenylprop-2-enal  (ISO)
4'-epidoxorubicin  (ISO)
4,4'-diisothiocyano-trans-stilbene-2,2'-disulfonic acid  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one  (ISO)
4-amino-2,6-dinitrotoluene  (EXP)
4-Aminobenzamide  (ISO)
4-aminofolic acid  (ISO)
4-chloroaniline  (ISO)
4-hydroperoxycyclophosphamide  (ISO)
4-hydroxy-TEMPO  (ISO)
4-hydroxynon-2-enal  (ISO)
4-hydroxyphenyl retinamide  (ISO)
4-methylumbelliferone  (ISO)
4-Nerolidylcatechol  (ISO)
4-nitrophenol  (ISO)
4-nitroquinoline N-oxide  (EXP,ISO)
4-nonylphenol  (EXP,ISO)
4-phenylbutyric acid  (EXP)
4-tert-Octylphenol  (EXP,ISO)
5'-S-methyl-5'-thioadenosine  (ISO)
5,6,7,8-tetrahydrobiopterin  (ISO)
5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole  (ISO)
5-(2-chloroethyl)-4-methylthiazole  (EXP)
5-aminolevulinic acid  (ISO)
5-aza-2'-deoxycytidine  (EXP,ISO)
5-azacytidine  (EXP,ISO)
5-chloro-7-iodoquinolin-8-ol  (ISO)
5-fluorouracil  (EXP,ISO)
5-Geranyloxy-7-methoxycoumarin  (ISO)
5-methoxypsoralen  (ISO)
6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide  (EXP,ISO)
6-O-methylguanine  (ISO)
6-oxocampestanol  (ISO)
6-propyl-2-thiouracil  (EXP)
7,12-dimethyltetraphene  (EXP,ISO)
7,8-diacetoxy-4-methylcoumarin  (ISO)
7,9-dihydro-1H-purine-2,6,8(3H)-trione  (ISO)
7-amino-4-hydroxy-2-naphthalenesulfonic acid  (ISO)
7-ketocholesterol  (EXP)
7-nitroindazole  (EXP)
8-Br-cAMP  (ISO)
8-bromo-3',5'-cyclic GMP  (EXP)
9,10-phenanthroquinone  (ISO)
9,11,13-octadecatrienoic acid  (ISO)
9-aminoacridine  (ISO)
9-Methoxycamptothecin  (ISO)
ABT-737  (ISO)
acetamide  (EXP)
acetamiprid  (ISO)
acetic acid  (ISO)
acetylsalicylic acid  (ISO)
aconitine  (EXP)
acridine orange  (ISO)
acridine orange free base  (ISO)
acrolein  (EXP,ISO)
acrylamide  (EXP,ISO)
acrylonitrile  (ISO)
actinomycin D  (ISO)
adavosertib  (ISO)
adefovir pivoxil  (ISO)
aflatoxin B1  (EXP,ISO)
Aflatoxin G1  (ISO)
AICA ribonucleotide  (ISO)
alantolactone  (ISO)
albendazole  (ISO)
albendazole S-oxide  (ISO)
albuterol  (ISO)
aldehydo-D-glucose  (EXP,ISO)
all-cis-docosa-7,10,13,16-tetraenoic acid  (ISO)
all-trans-retinoic acid  (EXP,ISO)
allethrin  (EXP)
alliin  (ISO)
allose  (ISO)
Aloe emodin  (ISO)
alpha-D-galactose  (EXP,ISO)
alpha-hexachlorocyclohexane  (EXP)
alpha-mangostin  (ISO)
alpha-naphthoflavone  (EXP,ISO)
alpha-phellandrene  (ISO)
alsterpaullone  (ISO)
alternariol  (ISO)
aluminium oxide  (ISO)
alvocidib  (ISO)
amifostine  (ISO)
amiodarone  (ISO)
ammonium chloride  (EXP,ISO)
amodiaquine  (ISO)
amosite asbestos  (EXP,ISO)
amphetamine  (EXP,ISO)
amphibole asbestos  (ISO)
amsacrine  (ISO)
andrographolide  (ISO)
anthra[1,9-cd]pyrazol-6(2H)-one  (EXP,ISO)
antimony trichloride  (ISO)
antimycin A  (ISO)
aphidicolin  (ISO)
apigenin  (ISO)
apocynin  (EXP)
arachidonic acid  (ISO)
arachidonyl-2'-chloroethylamide  (ISO)
arecoline  (ISO)
arecoline hydrobromide  (EXP)
Arg-Gly-Asp  (ISO)
aristolochic acid A  (ISO)
aristolochic acids  (ISO)
Aroclor 1254  (EXP,ISO)
arsane  (EXP,ISO)
arsenic acid  (ISO)
arsenic atom  (EXP,ISO)
arsenic trichloride  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (EXP,ISO)
artesunate  (ISO)
asbestos  (ISO)
aspartame  (ISO)
astaxanthin  (EXP)
astilbin  (ISO)
Atipamezole  (EXP)
atorvastatin calcium  (ISO)
ATP  (ISO)
Atranorin  (ISO)
atrasentan  (EXP)
atrazine  (EXP,ISO)
atropine  (ISO)
Auriculasin  (ISO)
aurofusarin  (ISO)
axitinib  (ISO)
azadirachtin A  (ISO)
azaribine  (ISO)
azathioprine  (ISO)
azetidine  (ISO)
azinphos-ethyl  (ISO)
azinphos-methyl  (ISO)
Azoxymethane  (EXP)
bafilomycin A1  (ISO)
baicalein  (EXP,ISO)
baicalin  (ISO)
barban  (ISO)
bathocuproine disulfonic acid  (ISO)
belinostat  (ISO)
benomyl  (ISO)
Bensulide  (ISO)
benzalkonium chloride  (ISO)
benzene  (EXP,ISO)
benzidine  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (ISO)
Benzo[a]pyrene-7,8-diol  (ISO)
benzo[b]fluoranthene  (ISO)
BENZO[G]CHRYSENE  (EXP)
Benzo[k]fluoranthene  (ISO)
berberine  (ISO)
beryllium dichloride  (ISO)
beryllium sulfate  (ISO)
Besigomsin  (ISO)
beta-carboline  (ISO)
beta-D-fructofuranose 1,6-bisphosphate  (ISO)
beta-lapachone  (ISO)
beta-naphthoflavone  (ISO)
betalain  (ISO)
betaxolol  (ISO)
betulinic acid  (ISO)
bexarotene  (ISO)
bicalutamide  (ISO)
bifenthrin  (ISO)
biphenyl-2-ol  (ISO)
biphenyl-4-amine  (ISO)
bis(2-chloroethyl) sulfide  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
Bisoxatin acetate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol AF  (ISO)
bisphenol F  (EXP,ISO)
bisphenol F diglycidyl ether  (ISO)
bithionol  (ISO)
bleomycin A2  (ISO)
boric acid  (ISO)
bortezomib  (ISO)
bosutinib  (ISO)
brassinolide  (ISO)
bromochloroacetic acid  (EXP)
Bromofos  (ISO)
Bromophos-ethyl  (ISO)
bromuconazole  (EXP)
bucladesine  (ISO)
budesonide  (ISO)
buspirone  (EXP)
busulfan  (ISO)
buta-1,3-diene  (ISO)
butanal  (ISO)
butane-2,3-dione  (ISO)
butylated hydroxyanisole  (EXP,ISO)
Butylbenzyl phthalate  (ISO)
butyric acid  (ISO)
C.I. Natural Red 20  (ISO)
C60 fullerene  (EXP,ISO)
cadmium acetate  (ISO)
cadmium atom  (EXP,ISO)
cadmium dichloride  (EXP,ISO)
caffeine  (EXP,ISO)
Calcimycin  (ISO)
calcitriol  (ISO)
calcium atom  (ISO)
calcium silicate  (ISO)
calcium(0)  (ISO)
calyculin A  (ISO)
camptothecin  (EXP,ISO)
candesartan  (EXP)
cannabidiol  (EXP,ISO)
capsaicin  (ISO)
carbachol  (ISO)
carbamate ester  (ISO)
carbamazepine  (ISO)
carbendazim  (EXP,ISO)
CARBENOXOLONE  (ISO)
carbofuran  (ISO)
carbon nanotube  (ISO)
Carbophenothion  (ISO)
carboplatin  (ISO)
carfilzomib  (ISO)
Carmofur  (ISO)
carmustine  (ISO)
carteolol  (ISO)
carvedilol  (EXP)
casticin  (ISO)
cefalotin  (ISO)
cefotaxime  (ISO)
celastrol  (ISO)
celecoxib  (EXP,ISO)
cepharanthine  (ISO)
ceric oxide  (ISO)
cerium  (ISO)
cetrorelix  (ISO)
CGS-21680  (ISO)
chalcones  (ISO)
chlorambucil  (ISO)
chlorfenvinfos  (ISO)
chloroacetaldehyde  (ISO)
chloroethene  (ISO)
chloroform  (EXP,ISO)
chlorogenic acid  (ISO)
chlorophyllin  (EXP,ISO)
chloropicrin  (ISO)
chloroquine  (ISO)
chlorpromazine  (EXP)
chlorpyrifos  (EXP,ISO)
chlorpyrifos-methyl  (ISO)
cholesterol  (ISO)
choline  (EXP,ISO)
chromium atom  (ISO)
chromium(6+)  (EXP,ISO)
chrysene  (ISO)
chrysin  (EXP,ISO)
chrysin 5,7-dimethyl ether  (EXP)
ciclopirox  (ISO)
cidofovir anhydrous  (ISO)
cilostazol  (EXP,ISO)
Cirsimarin  (ISO)
cis-caffeic acid  (ISO)
cisplatin  (EXP,ISO)
cladribine  (ISO)
clodronic acid  (ISO)
clofarabine  (ISO)
clofibric acid  (EXP)
clopidogrel  (ISO)
clotrimazole  (ISO)
clozapine  (ISO)
cobalt atom  (ISO)
cobalt dichloride  (EXP,ISO)
cocaine  (ISO)
coenzyme Q10  (EXP,ISO)
colforsin daropate hydrochloride  (ISO)
colistin  (EXP)
conjugated linoleic acid  (ISO)
copper atom  (EXP,ISO)
copper(0)  (EXP,ISO)
copper(II) chloride  (ISO)
copper(II) sulfate  (EXP,ISO)
cordycepin  (EXP,ISO)
coumaphos  (ISO)
coumarin  (ISO)
coumarin 460  (ISO)
Crenigacestat  (ISO)
cridanimod  (ISO)
crocidolite asbestos  (ISO)
crocin-1  (ISO)
crotonaldehyde  (EXP)
Crufomate  (ISO)
cryptolepine  (ISO)
crystal violet  (ISO)
CU-O LINKAGE  (ISO)
cudraflavone B  (ISO)
Cuprizon  (EXP,ISO)
curcumin  (EXP,ISO)
cyanamide  (EXP)
cycloheximide  (EXP,ISO)
cyclophosphamide  (EXP,ISO)
cyclosporin A  (EXP,ISO)
cyfluthrin  (ISO)
cyhalothrin  (ISO)
cylindrospermopsin  (EXP)
cypermethrin  (EXP,ISO)
cytarabine  (EXP,ISO)
cytochalasin B  (ISO)
D-fructofuranose 1,6-bisphosphate  (ISO)
D-glucose  (EXP,ISO)
D-mannitol  (ISO)
D-penicillamine  (ISO)
daidzein  (ISO)
dapagliflozin  (EXP)
DAPT  (ISO)
daunorubicin  (EXP,ISO)
DDE  (ISO)
DDT  (EXP,ISO)
deguelin  (ISO)
dehydroepiandrosterone  (ISO)
DENSPM  (ISO)
deoxycholic acid  (EXP)
Deoxycorticosterone acetate  (EXP)
deoxynivalenol  (ISO)
Deoxyschizandrin  (ISO)
dequalinium  (ISO)
desferrioxamine B  (EXP,ISO)
dexamethasone  (EXP,ISO)
dexmedetomidine  (EXP)
dextran sulfate  (ISO)
Di-n-octyl phthalate  (ISO)
Diacetoxyscirpenol  (ISO)
Dialifor  (ISO)
diallyl disulfide  (EXP,ISO)
Diallyl sulfide  (EXP,ISO)
diallyl trisulfide  (ISO)
diarsenic trioxide  (EXP,ISO)
diazinon  (EXP,ISO)
diazoxide  (EXP)
diazoxon  (ISO)
dibenz[a,h]anthracene  (ISO)
Dibenzo[a,e]pyrene  (EXP)
dibenzo[a,l]pyrene  (EXP,ISO)
Dibutyl phosphate  (ISO)
dibutyl phthalate  (EXP,ISO)
dichlorine  (ISO)
dichloroacetic acid  (ISO)
Dichlorophen  (ISO)
dichlorvos  (EXP)
dichromic acid  (ISO)
diclofenac  (EXP,ISO)
dicoumarol  (ISO)
dicrotophos  (ISO)
Dictamnine  (ISO)
dicyclanil  (ISO)
Didecyldimethylammonium  (ISO)
dieckol  (ISO)
dieldrin  (EXP,ISO)
dienestrol  (ISO)
diepoxybutane  (ISO)
diethanolamine  (EXP,ISO)
diethyl maleate  (ISO)
diethyl phthalate  (ISO)
diethyl sulfate  (ISO)
diethyldithiocarbamic acid  (ISO)
diethylstilbestrol  (EXP,ISO)
digitoxin  (ISO)
dihydroartemisinin  (ISO)
dihydrocapsaicin  (ISO)
dihydrolipoic acid  (ISO)
Diisodecyl phthalate  (ISO)
diisononyl phthalate  (ISO)
Dimefox  (ISO)
dimethylarsinic acid  (EXP,ISO)
dimetilan  (ISO)
dinophysistoxin 2  (ISO)
dioscin  (EXP,ISO)
diosmin  (EXP)
dioxygen  (EXP,ISO)
diphenoxylate  (ISO)
dipyridamole  (ISO)
diquat  (EXP)
disodium selenite  (ISO)
disulfoton  (ISO)
donepezil hydrochloride  (EXP)
dopamine  (ISO)
dorsomorphin  (ISO)
doxorubicin  (EXP,ISO)
edifenphos  (ISO)
eflornithine  (EXP)
EHT 1864  (ISO)
elemental selenium  (EXP,ISO)
ellagic acid  (EXP,ISO)
ellipticine  (ISO)
emodin  (EXP,ISO)
emtricitabine  (ISO)
endosulfan  (ISO)
endrin  (ISO)
entinostat  (ISO)
enzyme inhibitor  (ISO)
EPN  (ISO)
epoxiconazole  (ISO)
erdosteine  (ISO)
erlotinib hydrochloride  (ISO)
erythromycin estolate  (EXP)
erythrosin B  (ISO)
esculetin  (ISO)
estragole  (EXP)
etacrynic acid  (ISO)
ethacridine  (ISO)
ethanol  (EXP,ISO)
ethidium  (ISO)
ethion  (ISO)
ethyl 4-nitrophenyl ethylphosphonate  (ISO)
Ethyl acrylate  (ISO)
Ethyl icosapentate  (EXP)
ethylenediaminetetraacetic acid  (ISO)
etomoxir  (EXP)
etoposide  (EXP,ISO)
eugenol  (EXP,ISO)
EUK-134  (ISO)
eurycomanone  (ISO)
Evodiamine  (ISO)
famphur  (ISO)
fenamiphos  (ISO)
fenbendazole  (EXP,ISO)
fenitrothion  (EXP,ISO)
fenofibrate  (EXP,ISO)
fenpropathrin  (EXP)
fenpyroximate  (ISO)
fensulfothion  (ISO)
fenthion  (ISO)
fenticlor  (ISO)
fentin acetate  (ISO)
fenvalerate  (EXP)
ferric ammonium citrate  (EXP,ISO)
ferric oxide  (EXP)
ferrosoferric oxide  (ISO)
ferrostatin-1  (EXP)
finasteride  (EXP)
fingolimod hydrochloride  (ISO)
fipronil  (ISO)
fisetin  (EXP,ISO)
flavanone  (ISO)
flavanones  (ISO)
flavonoids  (ISO)
floxuridine  (ISO)
fluazinam  (ISO)
flubendazole  (ISO)
flucytosine  (ISO)
flumethrin  (ISO)
fluoranthene  (ISO)
fluorometholone  (ISO)
fluoxetine  (ISO)
flurbiprofen  (ISO)
flusalan  (ISO)
flutamide  (EXP)
folic acid  (EXP,ISO)
fonofos  (ISO)
formaldehyde  (EXP,ISO)
formic acid  (ISO)
formononetin  (EXP,ISO)
fosthiazate  (ISO)
fostriecin  (ISO)
fotemustine  (ISO)
fructose  (ISO)
fulvestrant  (ISO)
fumaraldehyde  (ISO)
fumonisin B1  (EXP,ISO)
furan  (EXP)
Fusarenone X  (ISO)
Fusaric acid  (ISO)
galactose  (EXP,ISO)
gallic acid  (ISO)
gamma-hexachlorocyclohexane  (ISO)
gamma-tocopherol  (ISO)
ganciclovir  (ISO)
gefitinib  (EXP,ISO)
geldanamycin  (ISO)
gemcitabine  (ISO)
Geniposide  (ISO)
genistein  (EXP,ISO)
gentamycin  (EXP,ISO)
geraniol  (EXP,ISO)
gingerol  (ISO)
ginkgolide B  (ISO)
ginsenoside Rg1  (ISO)
glafenine  (EXP)
gliclazide  (ISO)
glimepiride  (ISO)
glucaric acid  (ISO)
glucose  (EXP,ISO)
glutaraldehyde  (ISO)
glutathione  (ISO)
glutathione disulfide  (ISO)
Glutathione ethyl ester  (ISO)
glyburide  (EXP,ISO)
glycerol  (ISO)
glycine betaine  (EXP)
glycitein  (ISO)
glycoursodeoxycholic acid  (EXP)
glycyrrhetinate  (EXP)
glycyrrhetinic acid  (EXP)
glycyrrhizinic acid  (ISO)
glyphosate  (ISO)
gold atom  (ISO)
gold(0)  (ISO)
Goserelin  (ISO)
gossypol  (ISO)
graphene oxide  (ISO)
guggulsterone  (ISO)
GW 4064  (ISO)
GW 6471  (EXP)
Gyrophoric acid  (ISO)
haloperidol  (EXP)
harmalol  (ISO)
heparin  (ISO)
heptachlor  (ISO)
hesperetin  (ISO)
hesperidin  (EXP)
hexachlorophene  (ISO)
hexadecanoic acid  (ISO)
hexanal  (ISO)
homocysteine  (EXP,ISO)
hycanthone  (ISO)
hydralazine  (ISO)
hydrogen peroxide  (EXP,ISO)
hydroquinone  (ISO)
hydroxamic acid  (ISO)
hydroxychloroquine  (ISO)
hydroxyurea  (ISO)
ibuprofen  (ISO)
icariin  (ISO)
Icaritin  (ISO)
ICI D1694  (ISO)
ICI-164384  (ISO)
idarubicin  (ISO)
ifosfamide  (EXP,ISO)
indole-3-methanol  (ISO)
indometacin  (EXP,ISO)
Inotodiol  (ISO)
inuviscolide  (ISO)
Iodofenphos  (ISO)
iohexol  (ISO)
iopamidol  (ISO)
irinotecan  (ISO)
iron(III) nitrilotriacetate  (EXP)
isatin  (ISO)
Isazofos  (ISO)
isocarbophos  (ISO)
isocyanates  (ISO)
isofenphos  (ISO)
isoflavones  (EXP)
isoflurane  (EXP)
isoliquiritigenin  (ISO)
isoprenaline  (EXP,ISO)
isoprocarb  (ISO)
isotretinoin  (ISO)
isovitexin  (ISO)
ivermectin  (ISO)
juglone  (ISO)
kaempferol  (EXP,ISO)
kainic acid  (EXP)
ketamine  (ISO)
keto-D-fructose 1,6-bisphosphate  (ISO)
kojic acid  (EXP,ISO)
kresoxim-methyl  (ISO)
L-1,4-dithiothreitol  (ISO)
L-ascorbic acid  (EXP,ISO)
lactacystin  (EXP)
lactucin  (ISO)
lanreotide  (EXP)
lansoprazole  (EXP)
lapachol  (ISO)
lead diacetate  (EXP,ISO)
lead nitrate  (ISO)
lead(0)  (EXP,ISO)
leptomycin B  (EXP,ISO)
leptophos  (ISO)
levamisole  (ISO)
levetiracetam  (EXP)
lidocaine  (EXP,ISO)
limonene  (ISO)
linalool  (ISO)
lipoic acid  (EXP)
lipopolysaccharide  (EXP,ISO)
lithium atom  (ISO)
lithium chloride  (ISO)
lithium hydride  (ISO)
Lobetyolin  (ISO)
losartan  (EXP)
lovastatin  (EXP,ISO)
lupeol  (ISO)
luteolin  (EXP,ISO)
luzindole  (ISO)
LY294002  (EXP,ISO)
lycopene  (ISO)
lysophosphatidylcholine  (ISO)
lysophosphatidylethanolamine  (ISO)
maculosin  (ISO)
magnesium dichloride  (EXP)
magnesium oxide  (ISO)
malathion  (EXP,ISO)
maleimide  (ISO)
malonaldehyde  (ISO)
mancozeb  (ISO)
maneb  (ISO)
manganese atom  (EXP)
manganese(0)  (EXP)
manganese(II) chloride  (EXP)
mangiferin  (EXP)
masoprocol  (ISO)
mechlorethamine  (ISO)
medroxyprogesterone acetate  (ISO)
meglumine amidotrizoate  (EXP)
MeIQ  (ISO)
MeIQx  (EXP,ISO)
melatonin  (EXP,ISO)
melphalan  (ISO)
menadione  (ISO)
mercaptopurine  (ISO)
mercury atom  (ISO)
mercury dichloride  (ISO)
mercury(0)  (ISO)
metformin  (EXP,ISO)
methamidophos  (ISO)
methamphetamine  (EXP,ISO)
methapyrilene  (EXP)
methidathion  (ISO)
methoctramine tetrahydrochloride  (EXP)
methotrexate  (EXP,ISO)
methoxsalen  (ISO)
methoxyacetic acid  (ISO)
methoxychlor  (ISO)
methyl caffeate  (ISO)
methyl isocyanate  (ISO)
methyl methanesulfonate  (ISO)
methylarsonic acid  (ISO)
methylene bis(thiocyanate)  (ISO)
methylene blue  (ISO)
methylisothiazolinone  (ISO)
methylmercury chloride  (ISO)
metiram  (ISO)
mevinphos  (ISO)
microcystin  (EXP)
microcystin RR  (ISO)
microcystin-LR  (EXP,ISO)
midostaurin  (ISO)
mifepristone  (ISO)
minocycline  (EXP)
mitomycin C  (ISO)
Mitotane  (EXP,ISO)
mitoxantrone  (ISO)
MK-2206  (ISO)
molinate  (ISO)
molybdenum atom  (ISO)
mono(2-ethylhexyl) phthalate  (EXP,ISO)
monobenzone  (ISO)
monobenzyl phthalate  (ISO)
Monobutylphthalate  (EXP,ISO)
monocrotaline  (ISO)
monocrotophos  (EXP)
monomethyl succinate  (ISO)
monosodium L-glutamate  (ISO)
montelukast  (EXP)
morin  (EXP,ISO)
Morindone  (ISO)
morphine  (ISO)
motexafin gadolinium  (ISO)
mozavaptan  (ISO)
mycophenolic acid  (ISO)
myo-inositol hexakisphosphate  (EXP,ISO)
myricetin  (ISO)
myricitrin  (ISO)
myrtenal  (EXP)
Myrtucommulone A  (ISO)
N(gamma)-nitro-L-arginine methyl ester  (EXP)
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine  (ISO)
N,N-diethyl-m-toluamide  (EXP)
N,N-dimethylformamide  (ISO)
N-acetoxy-2-acetamidofluorene  (EXP)
N-acetyl-L-cysteine  (EXP,ISO)
N-acetylsphingosine  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (EXP,ISO)
N-butyl-N-(4-hydroxybutyl)nitrosamine  (ISO)
N-ethyl-N-nitrosourea  (EXP,ISO)
N-hydroxy-2-acetamidofluorene  (EXP)
N-hydroxy-4-aminobiphenyl  (ISO)
N-hydroxy-PhIP  (ISO)
N-methyl-4-phenylpyridinium  (EXP,ISO)
N-methyl-N'-nitro-N-nitrosoguanidine  (EXP,ISO)
N-methyl-N-nitrosourea  (EXP,ISO)
N-Nitrosodi-n-butylamine  (ISO)
N-nitrosodiethylamine  (EXP,ISO)
N-nitrosomorpholine  (EXP)
N-tosyl-L-phenylalanyl chloromethyl ketone  (ISO)
NAD zwitterion  (ISO)
NAD(+)  (ISO)
NADP zwitterion  (ISO)
NADP(+)  (ISO)
naloxone  (EXP,ISO)
naphthalene  (ISO)
naphthalenes  (ISO)
naringin  (EXP,ISO)
Neferine  (EXP)
neoastilbin  (ISO)
neocuproine  (ISO)
nickel atom  (ISO)
nickel dichloride  (EXP,ISO)
nickel ferrite  (ISO)
nickel subsulfide  (EXP)
nickel sulfate  (ISO)
niclosamide  (ISO)
nicorandil  (EXP)
nicotinamide  (ISO)
nicotine  (EXP,ISO)
nicotinic acid  (EXP)
nifedipine  (ISO)
nifuroxazide  (ISO)
nilotinib  (ISO)
nimustine  (ISO)
ninhydrin  (ISO)
nitenpyram  (ISO)
nitrates  (ISO)
nitric oxide  (EXP,ISO)
nitrofurazone  (ISO)
nitrogen dioxide  (EXP,ISO)
nitrogen mustard  (ISO)
nitroprusside  (EXP,ISO)
Nitrovin  (ISO)
NMS-873  (ISO)
nocodazole  (ISO)
Nonidet P-40  (ISO)
norethisterone  (ISO)
notoginsenoside R1  (ISO)
NS-398  (EXP,ISO)
Nutlin-3  (ISO)
O-(chloroacetylcarbamoyl)fumagillol  (ISO)
O-methyleugenol  (EXP)
Obacunone  (ISO)
ochratoxin A  (EXP,ISO)
Octicizer  (ISO)
octreotide  (ISO)
okadaic acid  (ISO)
olanzapine  (ISO)
olaparib  (ISO)
oleanolic acid  (ISO)
oleic acid  (ISO)
oleuropein  (EXP)
olomoucine  (ISO)
omacetaxine mepesuccinate  (ISO)
omethoate  (ISO)
orlistat  (EXP)
oroxylin A  (ISO)
ortho-Aminoazotoluene  (ISO)
ouabain  (ISO)
oxaliplatin  (ISO)
oxamyl  (ISO)
oxfendazole  (EXP)
oxidopamine  (EXP)
oxirane  (ISO)
oxybenzone  (EXP)
oxycarboxin  (ISO)
ozone  (EXP,ISO)
p-menthan-3-ol  (ISO)
p-tert-Amylphenol  (EXP,ISO)
paclitaxel  (ISO)
paeoniflorin  (ISO)
palbociclib  (ISO)
panobinostat  (ISO)
para-Cresidine  (ISO)
para-Nitrosodiphenylamine  (ISO)
paracetamol  (EXP,ISO)
paraoxon  (ISO)
Paraoxon-methyl  (ISO)
paraquat  (EXP,ISO)
parathion  (ISO)
parathion-methyl  (ISO)
parthenolide  (ISO)
patulin  (ISO)
pazopanib  (ISO)
PCB138  (ISO)
PD 0325901  (ISO)
PD 168393  (ISO)
pectolinarigenin  (ISO)
pemetrexed  (ISO)
pentachlorophenol  (EXP,ISO)
pentamidine  (ISO)
pentanal  (ISO)
pentetic acid  (ISO)
perfluorohexanesulfonic acid  (ISO)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (ISO)
pergolide  (ISO)
perifosine  (ISO)
permethrin  (EXP)
phenethyl caffeate  (EXP,ISO)
phenethyl isothiocyanate  (ISO)
phenindione  (ISO)
phenobarbital  (EXP,ISO)
phenol  (ISO)
phenylmercury acetate  (ISO)
phenytoin  (ISO)
PhIP  (ISO)
phloretin  (EXP,ISO)
phorate  (EXP,ISO)
phorbol 13-acetate 12-myristate  (EXP,ISO)
phosalone  (EXP)
phosmet  (ISO)
phosphamidon  (ISO)
phosphatidylcholine  (ISO)
phoxim  (ISO)
phthalaldehyde  (ISO)
picoxystrobin  (ISO)
pifithrin-alpha hydrobromide  (EXP,ISO)
pinostrobin  (ISO)
pinosylvin  (ISO)
piperine  (ISO)
Pirarubicin  (ISO)
pirimicarb  (ISO)
Pirimiphos-ethyl  (ISO)
pirinixic acid  (EXP)
piroxicam  (ISO)
PK-11195  (ISO)
platycodin D  (ISO)
plumbagin  (EXP)
poly(I:C)  (ISO)
poly(vinylpyrrolidone)  (ISO)
polymyxin B2  (ISO)
ponatinib  (ISO)
potassium bromate  (EXP,ISO)
potassium chloride  (EXP)
potassium chromate  (ISO)
potassium dichromate  (EXP,ISO)
potassium iodide  (EXP)
pravastatin  (EXP,ISO)
proanthocyanidin  (ISO)
procyanidin  (ISO)
procyanidin B1  (ISO)
progesterone  (EXP,ISO)
Promecarb  (ISO)
promethazine  (EXP)
propachlor  (ISO)
propanal  (ISO)
propetamphos  (ISO)
propofol  (EXP,ISO)
propylparaben  (ISO)
prothiofos  (ISO)
Ptaquiloside  (ISO)
pterostilbene  (ISO)
purine-6-thiol  (ISO)
pyrazophos  (ISO)
pyrene  (ISO)
Pyridostigmine bromide  (EXP)
pyrogallol  (ISO)
pyrroles  (ISO)
pyrrolidine dithiocarbamate  (EXP,ISO)
pyruvic acid  (EXP)
quartz  (EXP,ISO)
quercetin  (EXP,ISO)
quercetin 3-O-beta-D-glucofuranoside  (EXP)
quercetin 3-O-beta-D-glucopyranoside  (EXP)
quinacrine  (ISO)
quinalphos  (ISO)
quinidine  (EXP)
quinoline  (ISO)
quizartinib  (ISO)
raloxifene  (ISO)
razoxane  (ISO)
Reactive blue 2  (ISO)
reactive oxygen species  (ISO)
resveratrol  (EXP,ISO)
RGFP966  (ISO)
ribavirin  (ISO)
riboflavin  (ISO)
riddelliine  (EXP,ISO)
ritonavir  (ISO)
rivastigmine  (ISO)
romidepsin  (ISO)
Roridin A  (ISO)
rotenone  (EXP,ISO)
royal jelly  (ISO)
rubitecan  (ISO)
ruthenium atom  (EXP,ISO)
rutin  (EXP,ISO)
ruxolitinib  (ISO)
S-(1,2-dichlorovinyl)-L-cysteine  (ISO)
S-(2-Chloroethyl)glutathione  (ISO)
S-allylcysteine  (ISO)
S-butyl-DL-homocysteine (S,R)-sulfoximine  (EXP,ISO)
S-nitroso-L-cysteine  (ISO)
S-nitroso-N-acetyl-D-penicillamine  (ISO)
S-nitrosoglutathione  (EXP,ISO)
Salinomycin  (ISO)
salvianolic acid B  (EXP,ISO)
sappanchalcone  (ISO)
sapropterin  (ISO)
SB 203580  (EXP,ISO)
selenium atom  (EXP,ISO)
selenomethionine  (ISO)
selinexor  (ISO)
senecionine  (ISO)
serpentine asbestos  (EXP,ISO)
sevoflurane  (ISO)
Shikonin  (ISO)
sildenafil citrate  (ISO)
silibinin  (ISO)
silicon dioxide  (EXP,ISO)
silmitasertib  (ISO)
silver atom  (ISO)
silver(0)  (ISO)
silver(1+) nitrate  (ISO)
simvastatin  (EXP,ISO)
sinapic acid  (EXP)
sirolimus  (EXP,ISO)
sirtinol  (ISO)
skatole  (ISO)
sodium arsenite  (EXP,ISO)
sodium azide  (ISO)
sodium benzoate  (EXP,ISO)
sodium chloride  (EXP,ISO)
sodium cholate  (ISO)
sodium chromate  (ISO)
sodium dichromate  (EXP,ISO)
sodium disulfite  (ISO)
sodium fluoride  (ISO)
sodium hydrogencarbonate  (ISO)
Sodium salicylate  (EXP)
Soman  (ISO)
sorafenib  (ISO)
spermidine  (EXP)
starch  (ISO)
staurosporine  (EXP,ISO)
sterigmatocystin  (EXP)
stilbenoid  (ISO)
streptozocin  (EXP,ISO)
styrene oxide  (ISO)
succimer  (EXP)
sucrose  (ISO)
sulforaphane  (ISO)
sulfotep  (ISO)
sulfur dioxide  (EXP,ISO)
sulindac  (ISO)
sulindac sulfide  (ISO)
sulprofos  (ISO)
sunitinib  (EXP,ISO)
suramin  (ISO)
swainsonine  (ISO)
syringic acid  (ISO)
syringin  (ISO)
T-2 toxin  (EXP,ISO)
tacrine  (EXP)
tacrolimus hydrate  (EXP,ISO)
tamoxifen  (EXP,ISO)
tanespimycin  (ISO)
Tanshinone I  (ISO)
taurine  (EXP)
tauroursodeoxycholic acid  (EXP,ISO)
Tegafur  (ISO)
temozolomide  (ISO)
tenofovir disoproxil fumarate  (ISO)
terbufos  (ISO)
terbutylazine  (ISO)
Terfenadine  (ISO)
teriflunomide  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP,ISO)
tetrachloroethene  (ISO)
tetrachloromethane  (EXP,ISO)
tetrachlorvinphos  (ISO)
tetracycline  (EXP)
tetraphene  (ISO)
tetrathiomolybdate(2-)  (EXP,ISO)
tetrazolium violet  (ISO)
thalidomide  (ISO)
thapsigargin  (ISO)
theaflavin  (ISO)
theophylline  (EXP,ISO)
thiabendazole  (EXP)
thimerosal  (ISO)
thioacetamide  (EXP)
Thiobencarb  (ISO)
Thioinosine  (ISO)
thioridazine  (ISO)
thiostrepton  (ISO)
thiourea  (ISO)
thiram  (ISO)
thymoquinone  (ISO)
thyroxine  (EXP)
tioguanine  (ISO)
tipifarnib  (EXP)
tirapazamine  (ISO)
tiratricol  (ISO)
Tiron  (EXP)
titanium dioxide  (EXP,ISO)
tocopherol  (ISO)
tolbutamide  (EXP)
toluene  (EXP,ISO)
Tomentosin  (ISO)
toosendanin  (ISO)
topotecan  (ISO)
trans-caffeic acid  (ISO)
trans-piceid  (EXP)
trans-pinosylvin  (ISO)
triamterene  (ISO)
triazophos  (ISO)
tribufos  (ISO)
tributylstannane  (ISO)
trichlorfon  (ISO)
trichloroethene  (ISO)
trichostatin A  (EXP,ISO)
triclosan  (ISO)
triethyl phosphate  (ISO)
trifluridine  (ISO)
trimethyl phosphate  (ISO)
trimethylenediamine  (ISO)
trimethyltin  (ISO)
triphenyl phosphate  (ISO)
triphenylstannane  (ISO)
Triptolide  (EXP,ISO)
triptonide  (ISO)
tris(2,3-dibromopropyl) phosphate  (EXP)
tris(2-chloroethyl) phosphate  (ISO)
Tris(2-ethylhexyl) phosphate  (ISO)
troglitazone  (EXP,ISO)
tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate  (ISO)
tropisetron  (EXP)
Tryptanthrine  (ISO)
Tungsten carbide  (ISO)
tunicamycin  (EXP,ISO)
tyrphostin AG 1478  (ISO)
uracil  (ISO)
urethane  (ISO)
uridine  (ISO)
Urolithin A  (ISO)
ursodeoxycholic acid  (EXP,ISO)
usnic acid  (ISO)
valproic acid  (EXP,ISO)
valsartan  (EXP)
vanadium atom  (EXP,ISO)
vanadium dioxide  (ISO)
vanadium(0)  (EXP,ISO)
vancomycin  (EXP)
vanillin  (ISO)
venlafaxine hydrochloride  (EXP)
venom  (ISO)
versicolorin A  (ISO)
vincaleukoblastine  (ISO)
vinclozolin  (EXP,ISO)
vincristine  (ISO)
vitamin D  (ISO)
vitamin E  (EXP,ISO)
vorinostat  (ISO)
warfarin  (ISO)
WIN 55212-2  (ISO)
withaferin A  (ISO)
Withanone  (ISO)
wogonin  (ISO)
wortmannin  (EXP,ISO)
Xanthatin  (ISO)
xanthohumol  (ISO)
XMU-MP-1  (ISO)
Y-27632  (ISO)
zearalenone  (ISO)
zebularine  (ISO)
zerumbone  (ISO)
zidovudine  (ISO)
zinc acetate  (ISO)
zinc atom  (EXP,ISO)
zinc dichloride  (ISO)
zinc molecular entity  (ISO)
zinc oxide  (ISO)
zinc protoporphyrin  (EXP,ISO)
zinc pyrithione  (ISO)
zinc sulfate  (ISO)
zinc(0)  (EXP,ISO)
zoledronic acid  (ISO)
zoxamide  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
apoptotic process  (IEA,ISO)
apoptotic signaling pathway  (IMP)
autophagy  (IEA,ISO)
B cell lineage commitment  (IEA,ISO)
bone marrow development  (IEA,ISO)
cardiac muscle cell apoptotic process  (IEA,ISO)
cardiac septum morphogenesis  (IEA,ISO)
cell population proliferation  (IEA,ISO)
cellular response to actinomycin D  (IEA,ISO)
cellular response to gamma radiation  (IEA,ISO)
cellular response to glucose starvation  (IEA,ISO)
cellular response to heat  (IEP)
cellular response to hypoxia  (IEA,IEP,ISO)
cellular response to ionizing radiation  (IEA,ISO)
cellular response to polyamine macromolecule  (IEP)
cellular response to reactive oxygen species  (IMP)
cellular response to stress  (IEA,ISO)
cellular response to triglyceride  (IEP)
cellular response to UV  (IEA,ISO)
cellular response to UV-C  (IEA,ISO)
cellular response to xenobiotic stimulus  (IEA,ISO)
cellular senescence  (IEA,ISO,ISS)
central nervous system development  (IEA,ISO)
cerebellum development  (IEA,ISO)
chromosome organization  (IEA,ISO)
circadian behavior  (IEA,ISO,ISS)
circadian rhythm  (IEA,ISO)
determination of adult lifespan  (IEA,ISO)
DNA damage response  (IEA,ISO,ISS)
DNA damage response, signal transduction by p53 class mediator  (IEA,ISO)
double-strand break repair  (IEA,ISO)
embryo development ending in birth or egg hatching  (IEA,ISO)
embryonic organ development  (IEA,ISO)
entrainment of circadian clock by photoperiod  (IEA,ISO,ISS)
ER overload response  (IEA,ISO)
fibroblast proliferation  (IEA,ISO)
gastrulation  (IEA,ISO)
glial cell proliferation  (IEA,ISO)
glucose catabolic process to lactate via pyruvate  (IEA,ISO)
heart development  (IEA,ISO)
hematopoietic progenitor cell differentiation  (IEA,ISO)
hematopoietic stem cell differentiation  (IEA,ISO)
in utero embryonic development  (IEA,ISO)
intrinsic apoptotic signaling pathway by p53 class mediator  (IEA,ISO)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator  (IEA,ISO)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress  (IEA,ISO)
intrinsic apoptotic signaling pathway in response to hypoxia  (IEA,ISO)
mitochondrial DNA repair  (IEA,ISO)
mitophagy  (IEA,ISO)
mitotic G1 DNA damage checkpoint signaling  (IEA,ISO)
mRNA transcription  (IEA,ISO)
multicellular organism growth  (IEA,ISO)
necroptotic process  (IEA,ISO)
negative regulation of apoptotic process  (IEA,IMP,ISO)
negative regulation of cell growth  (IEA,ISO,ISS)
negative regulation of cell population proliferation  (IEA,IMP,ISO)
negative regulation of DNA biosynthetic process  (IMP)
negative regulation of DNA replication  (IEA,ISO)
negative regulation of DNA-templated transcription  (IDA,IEA,ISO)
negative regulation of fibroblast proliferation  (IEA,ISO)
negative regulation of G1 to G0 transition  (IEA,ISO)
negative regulation of gene expression  (IEA,ISO)
negative regulation of glial cell proliferation  (IEA,ISO)
negative regulation of glucose catabolic process to lactate via pyruvate  (IEA,ISO)
negative regulation of miRNA processing  (IEA,ISO)
negative regulation of mitophagy  (IEA,ISO)
negative regulation of mitotic cell cycle  (IEA,ISO)
negative regulation of neuroblast proliferation  (IEA,ISO)
negative regulation of pentose-phosphate shunt  (IEA,ISO)
negative regulation of progesterone secretion  (ISO)
negative regulation of proteolysis  (IEA,ISO)
negative regulation of reactive oxygen species metabolic process  (IEA,ISO)
negative regulation of smooth muscle cell proliferation  (IMP)
negative regulation of stem cell proliferation  (IEA,ISO)
negative regulation of telomere maintenance via telomerase  (IEA,ISO)
negative regulation of transcription by RNA polymerase II  (IEA,ISO)
negative regulation of transforming growth factor beta receptor signaling pathway  (IEA,ISO)
neuroblast proliferation  (IEA,ISO)
neuron apoptotic process  (IEA,ISO)
nucleotide-excision repair  (IEA,ISO,ISS)
oligodendrocyte apoptotic process  (IEA,ISO,ISS)
oxidative stress-induced premature senescence  (IEA,ISO)
positive regulation of apoptotic process  (IEA,IMP,ISO,ISS)
positive regulation of cardiac muscle cell apoptotic process  (IEA,ISO)
positive regulation of cell cycle  (IMP)
positive regulation of cellular senescence  (IEA,ISO)
positive regulation of DNA-templated transcription  (IEA,ISO)
positive regulation of execution phase of apoptosis  (IEA,ISO)
positive regulation of gene expression  (IEA,IGI,ISO)
positive regulation of intrinsic apoptotic signaling pathway  (IEA,IMP,ISO,ISS)
positive regulation of leukocyte migration  (IMP)
positive regulation of miRNA transcription  (IEA,ISO)
positive regulation of mitochondrial membrane permeability  (IEA,ISO)
positive regulation of neuron apoptotic process  (IEA,ISO)
positive regulation of outer hair cell apoptotic process  (ISO)
positive regulation of programmed necrotic cell death  (IEA,ISO)
positive regulation of reactive oxygen species metabolic process  (IEA,ISO)
positive regulation of release of cytochrome c from mitochondria  (IEA,ISO)
positive regulation of RNA polymerase II transcription preinitiation complex assembly  (IEA,ISO)
positive regulation of thymocyte apoptotic process  (IEA,ISO)
positive regulation of transcription by RNA polymerase II  (IDA,IEA,ISO)
programmed cell death  (IEA)
protein import into nucleus  (IEA,ISO)
protein localization  (IEA,ISO)
protein stabilization  (IEA,ISO)
protein tetramerization  (IEA)
protein-containing complex assembly  (IEA,ISO)
Ras protein signal transduction  (IEA,ISO)
reactive oxygen species metabolic process  (IEA,ISO)
regulation of apoptotic process  (IEA,ISO)
regulation of cell cycle  (IEA,IMP,ISO)
regulation of cell cycle G2/M phase transition  (IEA,ISO)
regulation of cell population proliferation  (IEA,ISO)
regulation of cellular senescence  (IEA,ISO)
regulation of DNA damage response, signal transduction by p53 class mediator  (IEA,ISO)
regulation of DNA-templated transcription  (IEA,ISO)
regulation of fibroblast apoptotic process  (IEA,ISO)
regulation of intracellular pH  (IMP)
regulation of intrinsic apoptotic signaling pathway by p53 class mediator  (IEA,ISO)
regulation of mitochondrial membrane permeability involved in apoptotic process  (IEA,ISO)
regulation of mitotic cell cycle  (IEA,ISO)
regulation of neuron apoptotic process  (IEA,ISO)
regulation of peptide hormone secretion  (ISO)
regulation of prostaglandin secretion  (ISO)
regulation of thymocyte apoptotic process  (IEA,ISO)
regulation of tissue remodeling  (IEA,ISO)
regulation of transcription by RNA polymerase II  (IBA,IEA,ISO)
release of cytochrome c from mitochondria  (IEA,ISO)
replicative senescence  (IEA,ISO)
response to amino acid  (IEP)
response to antibiotic  (IEA,ISO)
response to benzene  (IEP)
response to caffeine  (IEP)
response to cytokine  (IEP)
response to ethanol  (IEP)
response to gamma radiation  (IEA,ISO)
response to hyperoxia  (IEP)
response to hypoxia  (ISO)
response to ischemia  (IEA,ISO)
response to metal ion  (IEP)
response to oxidative stress  (IEA,IEP,ISO)
response to retinoic acid  (IEP)
response to salt stress  (IEA,ISO)
response to UV  (IEA,IEP,ISO)
response to UV-B  (IEP)
response to vitamin B3  (IEP)
response to X-ray  (IEA,IEP,IMP,ISO)
response to xenobiotic stimulus  (IEA,IEP,ISO)
rhythmic process  (IEA)
rRNA transcription  (IEA,ISO)
signal transduction by p53 class mediator  (IEA,ISO)
somitogenesis  (IEA,ISO)
spermatogenesis  (IMP)
stem cell proliferation  (IEA,ISO)
T cell differentiation in thymus  (IEA,ISO)
T cell lineage commitment  (IEA,ISO)
T cell proliferation involved in immune response  (IEA,ISO)
thymocyte apoptotic process  (IEA,ISO)
transcription initiation-coupled chromatin remodeling  (IEA,ISO)
transforming growth factor beta receptor signaling pathway  (IEA,ISO)
tumor necrosis factor-mediated signaling pathway  (IEA,ISO)
type II interferon-mediated signaling pathway  (IEA,ISO)
viral process  (IEA,ISO)

Cellular Component
centrosome  (IEA,ISO,ISS)
chromatin  (IDA,IEA,ISO)
cytoplasm  (IEA,ISO,ISS)
cytoskeleton  (IEA)
cytosol  (IEA,ISO)
endoplasmic reticulum  (IEA)
germ cell nucleus  (IEA,ISO)
mitochondrial matrix  (IEA,ISO)
mitochondrion  (IEA,ISO,ISS)
nuclear body  (IEA,ISO)
nuclear matrix  (IEA,ISO)
nucleolus  (IEA,ISO,ISS)
nucleoplasm  (IEA,ISO)
nucleus  (IDA,IEA,ISO,ISS)
PML body  (IDA,IEA,ISO)
protein-containing complex  (IEA,ISO)
replication fork  (IEA,ISO)
RNA polymerase II transcription regulator complex  (IDA)
site of double-strand break  (IEA,ISO)
transcription regulator complex  (IDA,IEA,ISO)
transcription repressor complex  (IEA,ISO)

Molecular Function
14-3-3 protein binding  (ISO)
ATP-dependent DNA/DNA annealing activity  (IEA,ISO,ISS)
chromatin binding  (IEA,ISO)
cis-regulatory region sequence-specific DNA binding  (IEA,ISO)
copper ion binding  (IEA,ISO,ISS)
core promoter sequence-specific DNA binding  (IEA,ISO)
disordered domain specific binding  (IEA,ISO)
DNA binding  (IEA,ISO,ISS)
DNA-binding transcription activator activity, RNA polymerase II-specific  (IEA,ISO)
DNA-binding transcription factor activity  (IEA,ISO)
DNA-binding transcription factor activity, RNA polymerase II-specific  (IBA,IEA,ISO,ISS)
DNA-binding transcription repressor activity, RNA polymerase II-specific  (IEA,ISO)
enzyme binding  (IEA,ISO)
general transcription initiation factor binding  (IEA,ISO)
histone deacetylase binding  (IEA,ISO)
histone deacetylase regulator activity  (IEA,ISO)
identical protein binding  (IEA,ISO)
MDM2/MDM4 family protein binding  (IEA,IPI,ISO)
metal ion binding  (IEA)
molecular condensate scaffold activity  (IEA,ISO,ISS)
molecular function activator activity  (IEA,ISO)
mRNA 3'-UTR binding  (IEA,ISO)
p53 binding  (IEA,ISO)
promoter-specific chromatin binding  (IEA,ISO,ISS)
protease binding  (IEA,ISO)
protein binding  (IPI,ISO)
protein heterodimerization activity  (IEA,ISO)
protein phosphatase 2A binding  (IEA,ISO)
protein-folding chaperone binding  (IEA,ISO)
receptor tyrosine kinase binding  (IEA,ISO)
RNA polymerase II cis-regulatory region sequence-specific DNA binding  (IBA,IEA,ISO,ISS)
RNA polymerase II transcription regulatory region sequence-specific DNA binding  (IEA,ISO)
RNA polymerase II-specific DNA-binding transcription factor binding  (IEA,IPI,ISO)
sequence-specific DNA binding  (IDA)
TFIID-class transcription factor complex binding  (IEA,ISO)
transcription cis-regulatory region binding  (IEA,ISO)
transcription coactivator binding  (IEA,ISO)
transcription coregulator binding  (IPI)
transmembrane transporter binding  (IPI)
ubiquitin protein ligase binding  (IEA,IPI,ISO)

Phenotype Annotations     Click to see Annotation Detail View
References

References - curated
# Reference Title Reference Citation
1. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension. Abid S, etal., Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):304-12. doi: 10.1161/ATVBAHA.113.302302. Epub 2013 Dec 12.
2. Polymorphisms of DNA damage response genes in radiation-related and sporadic papillary thyroid carcinoma. Akulevich NM, etal., Endocr Relat Cancer. 2009 Jun;16(2):491-503. doi: 10.1677/ERC-08-0336. Epub 2009 Mar 13.
3. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. Alam M and Mishra R, Life Sci. 2021 Sep 1;280:119705. doi: 10.1016/j.lfs.2021.119705. Epub 2021 Jun 8.
4. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Albino AP, etal., Am J Otol. 1998 Jan;19(1):30-6.
5. The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer. Almquist LM, etal., Carcinogenesis. 2011 Mar;32(3):327-30. doi: 10.1093/carcin/bgq256. Epub 2010 Dec 1.
6. TP53 Gene Pro72Arg (rs1042522) Single Nucleotide Polymorphism as Not a Risk Factor for Colorectal Cancer in the Iranian Azari Population Asadi M, etal., Asian Pac J Cancer Prev. 2017 Dec 29;18(12):3423-3427. doi: 10.22034/APJCP.2017.18.12.3423.
7. p53 expression and apoptosis in the lens after ultraviolet radiation exposure. Ayala M, etal., Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4187-91.
8. Prognosis of adenocarcinoma of the uterine cervix: p53 expression correlates with higher incidence of mortality. Baalbergen A, etal., Int J Cancer. 2007 Jul 1;121(1):106-10.
9. Prognostic value of TP53 gene mutations in myelodysplastic syndromes and acute myeloid leukemia treated with azacitidine. Bally C, etal., Leuk Res. 2014 Jul;38(7):751-5. doi: 10.1016/j.leukres.2014.03.012. Epub 2014 Mar 23.
10. The molecular biology of endometrial cancers and the implications for pathogenesis, classification, and targeted therapies. Bansal N, etal., Cancer Control. 2009 Jan;16(1):8-13.
11. The mutational landscape of prostate cancer. Barbieri CE, etal., Eur Urol. 2013 Oct;64(4):567-76. doi: 10.1016/j.eururo.2013.05.029. Epub 2013 May 18.
12. The genetic association database. Becker KG, etal., Nat Genet. 2004 May;36(5):431-2.
13. Targeted-simultaneous expression of Gas1 and p53 using a bicistronic adenoviral vector in gliomas. Benitez JA, etal., Cancer Gene Ther. 2007 Oct;14(10):836-46. Epub 2007 Jun 29.
14. Thiol alkylation inhibits the mitogenic effects of platelet-derived growth factor and renders it proapoptotic via activation of STATs and p53 and induction of expression of caspase1 and p21(waf1/cip1). Bhanoori M, etal., Oncogene 2003 Jan 9;22(1):117-30.
15. The 5' region of the p53 gene: evolutionary conservation and evidence for a negative regulatory element. Bienz-Tadmor B, etal., EMBO J 1985 Dec 1;4(12):3209-13.
16. Caveolin-1/PTRF upregulation constitutes a mechanism for mediating p53-induced cellular senescence: implications for evidence-based therapy of delayed wound healing in diabetes. Bitar MS, etal., Am J Physiol Endocrinol Metab. 2013 Oct 15;305(8):E951-63. doi: 10.1152/ajpendo.00189.2013. Epub 2013 Aug 13.
17. Expression of p53 in arsenic-related and sporadic basal cell carcinoma. Boonchai W, etal., Arch Dermatol. 2000 Feb;136(2):195-8.
18. Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma. Bossi P, etal., Oral Oncol. 2013 May;49(5):413-9. doi: 10.1016/j.oraloncology.2012.12.011. Epub 2013 Jan 29.
19. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. Budhram-Mahadeo V, etal., J Biol Chem. 1999 May 21;274(21):15237-44. doi: 10.1074/jbc.274.21.15237.
20. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease. Bufalo NE, etal., Clin Endocrinol (Oxf). 2008 Jun;68(6):982-7. Epub 2007 Nov 2.
21. Stabilization and activation of p53 by the coactivator protein TAFII31. Buschmann T, etal., J Biol Chem. 2001 Apr 27;276(17):13852-7. Epub 2001 Feb 1.
22. TP53 suppression promotes erythropoiesis in del(5q) MDS, suggesting a targeted therapeutic strategy in lenalidomide-resistant patients. Caceres G, etal., Proc Natl Acad Sci U S A. 2013 Oct 1;110(40):16127-32. doi: 10.1073/pnas.1311055110. Epub 2013 Sep 16.
23. Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675. Cai B, etal., J Pineal Res. 2016 Aug;61(1):82-95. doi: 10.1111/jpi.12331. Epub 2016 Apr 29.
24. Nupr1/Chop signal axis is involved in mitochondrion-related endothelial cell apoptosis induced by methamphetamine. Cai D, etal., Cell Death Dis. 2016 Mar 31;7:e2161. doi: 10.1038/cddis.2016.67.
25. Effects of chronic treatment with valproate and oxcarbazepine on ovarian folliculogenesis in rats. Cansu A, etal., Epilepsia. 2008 Mar 10;.
26. p53 Suppression partially rescues the mutant phenotype in mouse models of DiGeorge syndrome. Caprio C and Baldini A, Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13385-90. doi: 10.1073/pnas.1401923111. Epub 2014 Sep 2.
27. Analysis of p53 and NF-kappaB signaling in modulating the cardiomyocyte fate during hypertrophy. Chatterjee A, etal., J Cell Physiol. 2011 Oct;226(10):2543-54. doi: 10.1002/jcp.22599.
28. p53 nuclear expression correlates with hemizygous TP53 deletion and predicts an adverse outcome for patients with relapsed/refractory multiple myeloma treated with lenalidomide. Chen MH, etal., Am J Clin Pathol. 2012 Feb;137(2):208-12. doi: 10.1309/AJCPHC85DGAXZDBE.
29. High p53 protein expression in therapy-related myeloid neoplasms is associated with adverse karyotype and poor outcome. Cleven AH, etal., Mod Pathol. 2015 Apr;28(4):552-63. doi: 10.1038/modpathol.2014.153. Epub 2014 Nov 21.
30. Importance of TP53 codon 72 and intron 3 duplication 16bp polymorphisms in prediction of susceptibility on breast cancer. Costa S, etal., BMC Cancer. 2008 Jan 29;8:32.
31. Differential gene expression in mouse mammary adenocarcinomas in the presence and absence of wild type p53. Cui XS and Donehower LA, Oncogene. 2000 Dec 7;19(52):5988-96.
32. Prognostic factors in head and neck adenoid cystic carcinoma. da Cruz Perez DE, etal., Oral Oncol. 2006 Feb;42(2):139-46. Epub 2005 Oct 24.
33. Spontaneous testicular atrophy occurs despite normal spermatogonial proliferation in a Tp53 knockout rat. Dai MS, etal., Andrology. 2017 Nov;5(6):1141-1152. doi: 10.1111/andr.12409. Epub 2017 Aug 22.
34. Activation of p53 enhances apoptosis and insulin resistance in a rat model of alcoholic liver disease. Derdak Z, etal., J Hepatol. 2011 Jan;54(1):164-72. doi: 10.1016/j.jhep.2010.08.007. Epub 2010 Sep 6.
35. A spontaneous model of spondyloarthropathies that develops bone loss and pathological bone formation: A process regulated by IL27RA-/- and mutant-p53. Dibra D, etal., PLoS One. 2018 Mar 1;13(3):e0193485. doi: 10.1371/journal.pone.0193485. eCollection 2018.
36. Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation. Ebrahimi M, etal., J Oral Pathol Med. 2006 Jan;35(1):46-50.
37. Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinoma. Eccles DM, etal., Br J Cancer. 1992 Jan;65(1):40-4.
38. TP53 mutation in prostate needle biopsies--comparison with patients follow-up. Ecke TH, etal., Anticancer Res. 2007 Nov-Dec;27(6B):4143-8.
39. Apoptosis as a mechanism of maxillary sinus mucosa injury in rats after experimental transection of the maxillary nerve. Edranov SS and Motavkin PA, Bull Exp Biol Med. 2012 Aug;153(4):526-9.
40. Gene abnormalities in multiple myeloma; the relevance of TP53, MDM2, and CDKN2A. Elnenaei MO, etal., Haematologica. 2003 May;88(5):529-37.
41. Genetic polymorphisms of TP53 Arg72Pro and Pro47Ser among Egyptian patients with colorectal carcinoma. Elsaid A, etal., Arch Physiol Biochem. 2019 Jul;125(3):255-262. doi: 10.1080/13813455.2018.1453522. Epub 2018 Mar 21.
42. Association of polymorphisms of tumor necrosis factor and tumor protein p53 with primary open-angle glaucoma. Fan BJ, etal., Invest Ophthalmol Vis Sci. 2010 Aug;51(8):4110-6. doi: 10.1167/iovs.09-4974. Epub 2010 Mar 31.
43. Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1. Fan H, etal., J Immunol Res. 2018 Jan 10;2018:5408324. doi: 10.1155/2018/5408324. eCollection 2018.
44. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring]. Fan P, etal., Zhonghua Yi Xue Za Zhi. 2017 Sep 12;97(34):2670-2673. doi: 10.3760/cma.j.issn.0376-2491.2017.34.006.
45. [Establishment of a rat model of dimethylbenzanthracene-induced vulvar squamous intraepithelial lesions]. Fan Y, etal., Nan Fang Yi Ke Da Xue Xue Bao. 2018 Nov 30;38(11):1318-1324. doi: 10.12122/j.issn.1673-4254.2018.11.07.
46. Assessment of p53 protein expression in normal mucosa and benign and malignant lesions of the nasal cavity. Fang SY, etal., Oncology. 1998 Mar-Apr;55(2):168-73.
47. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein. Frebourg T, etal., Proc Natl Acad Sci U S A. 1992 Jul 15;89(14):6413-7.
48. Mutant p53: one name, many proteins. Freed-Pastor WA and Prives C, Genes Dev. 2012 Jun 15;26(12):1268-86. doi: 10.1101/gad.190678.112.
49. Kinetics of GADD45alpha, TP53 and CASP3 gene expression in the rat lens in vivo in response to exposure to double threshold dose of UV-B radiation. Galichanin K, etal., Exp Eye Res. 2012 Apr;97(1):19-23. doi: 10.1016/j.exer.2012.02.003. Epub 2012 Feb 13.
50. Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Gao Y, etal., Nature 2000 Apr 20;404(6780):897-900.
51. [Immunohistochemical study of the predictive value of oncoproteins p53, HER-2 and c-myc during radiotherapy for squamous cell carcinoma of the cervix] Gasparian NA, etal., Vopr Onkol. 2007;53(4):439-44.
52. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
53. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
54. Expression and Prognostic Significance of EP300, TP53 and BAX in Clear Cell Renal Cell Carcinoma. Godlewski J, etal., Anticancer Res. 2017 Jun;37(6):2927-2937. doi: 10.21873/anticanres.11646.
55. Prognostic value of combined p53 and survivin in pT1G3 urothelial carcinoma of the bladder. Gonzalez S, etal., Am J Clin Pathol. 2008 Feb;129(2):232-7.
56. Squamous cell carcinoma of the oropharynx: Ki-67 and p53 can identify patients at high risk for local recurrence after surgery and postoperative radiotherapy. Grabenbauer GG, etal., Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4):1041-50.
57. Comprehensive analysis of the p53 status in mucosal and cutaneous melanomas. Gwosdz C, etal., Int J Cancer. 2006 Feb 1;118(3):577-82.
58. Transcriptional repression of taurine transporter gene (TauT) by p53 in renal cells. Han X, etal., J Biol Chem 2002 Oct 18;277(42):39266-73.
59. Fischer-344 Tp53-knockout rats exhibit a high rate of bone and brain neoplasia with frequent metastasis. Hansen SA, etal., Dis Model Mech. 2016 Oct 1;9(10):1139-1146. Epub 2016 Aug 15.
60. P53 expression in vulvar carcinoma, vulvar intraepithelial neoplasia, squamous cell hyperplasia and lichen sclerosus. Hantschmann P, etal., Anticancer Res. 2005 May-Jun;25(3A):1739-45.
61. Uterine Carcinomas in Tetrabromobisphenol A-exposed Wistar Han Rats Harbor Increased Tp53 Mutations and Mimic High-grade Type I Endometrial Carcinomas in Women. Harvey JB, etal., Toxicol Pathol. 2015 Dec;43(8):1103-13. doi: 10.1177/0192623315599256. Epub 2015 Sep 8.
62. Codon 72 polymorphism of TP53 gene is a novel prognostic marker for therapy in multiple myeloma. Hattori Y, etal., Br J Haematol. 2014 Jun;165(5):728-31. doi: 10.1111/bjh.12784. Epub 2014 Feb 24.
63. Mutant p53(R270H) gain of function phenotype in a mouse model for oncogene-induced mammary carcinogenesis. Heinlein C, etal., Int J Cancer. 2008 Apr 15;122(8):1701-9.
64. Mutations in TP53 tumor suppressor gene in wood dust-related sinonasal cancer. Holmila R, etal., Int J Cancer. 2010 Aug 1;127(3):578-88. doi: 10.1002/ijc.25064.
65. Kras, Egfr, and Tp53 Mutations in B6C3F1/N Mouse and F344/NTac Rat Alveolar/Bronchiolar Carcinomas Resulting from Chronic Inhalation Exposure to Cobalt Metal. Hong HH, etal., Toxicol Pathol. 2015 Aug;43(6):872-82. doi: 10.1177/0192623315581192. Epub 2015 Jun 9.
66. Elevated p53 protein expression; a predictor of relapse in rare chronic myeloid malignancies in children? Honkaniemi E, etal., Pediatr Hematol Oncol. 2014 May;31(4):327-39. doi: 10.3109/08880018.2014.898723.
67. p53 and p21WAF1/CIP1 overexpression at the invasive front of lower lip squamous cell carcinoma. Horta MC, etal., J Oral Pathol Med. 2007 Feb;36(2):88-92.
68. Multiple apoptotic pathways induced by p53-dependent acidification in benzopyrene-exposed hepatic F258 cells. Huc L, etal., J Cell Physiol. 2006 Sep;208(3):527-37.
69. Structure of the rat p53 tumor suppressor gene. Hulla JE and Schneider RP, Nucleic Acids Res 1993 Feb 11;21(3):713-7.
70. Genetic variants of TP53 and EPHX1 in Leber's hereditary optic neuropathy and their relationship to age at onset. Ishikawa K, etal., Jpn J Ophthalmol. 2005 Mar-Apr;49(2):121-6.
71. Hyperthermia-induced apoptosis in two rat yolk sac tumor cell lines with different radiothermosensitivity in vitro. Islam MS, etal., Oncol Rep. 2001 May-Jun;8(3):501-7.
72. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Jones S, etal., Science. 2008 Sep 26;321(5897):1801-6. Epub 2008 Sep 4.
73. Role of reactive oxygen species in p53 activation during cisplatin-induced apoptosis of rat mesangial cells. Ju SM, etal., Eur Rev Med Pharmacol Sci. 2014;18(8):1135-41.
74. Subcellular localization of Daxx determines its opposing functions in ischemic cell death. Jung YS, etal., FEBS Lett. 2007 Mar 6;581(5):843-52. Epub 2007 Feb 2.
75. P53 overexpression in bladder urothelial neoplasms: new aspect of world health organization/international society of urological pathology classification. Kalantari MR and Ahmadnia H, Urol J. 2007 Fall;4(4):230-3.
76. The association of immunoreactive p53 and Ki-67 with T-stage, grade, occurrence of metastases and survival in renal cell carcinoma. Kankuri M, etal., Anticancer Res. 2006 Sep-Oct;26(5B):3825-33.
77. Oxidative stress regulates IGF1R expression in vascular smooth-muscle cells via p53 and HDAC recruitment. Kavurma MM, etal., Biochem J. 2007 Oct 1;407(1):79-87.
78. KEGG: Kyoto Encyclopedia of Genes and Genomes KEGG
79. Premature aging in vitamin D receptor mutant mice. Keisala T, etal., J Steroid Biochem Mol Biol. 2009 Jul;115(3-5):91-7. doi: 10.1016/j.jsbmb.2009.03.007. Epub 2009 Mar 31.
80. Diabetes-Induced Oxidative DNA Damage Alters p53-p21CIP1/Waf1 Signaling in the Rat Testis. Kilarkaje N and Al-Bader MM, Reprod Sci. 2014 May 14. pii: 1933719114533729.
81. Clusterin regulates ß-amyloid toxicity via Dickkopf-1-driven induction of the wnt-PCP-JNK pathway. Killick R, etal., Mol Psychiatry. 2014 Jan;19(1):88-98. doi: 10.1038/mp.2012.163. Epub 2012 Nov 20.
82. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. Kim D, etal., EMBO J. 2007 Jul 11;26(13):3169-79. Epub 2007 Jun 21.
83. Overexpression and mutation of p53 in endometrial carcinoma. Kohler MF, etal., Cancer Res. 1992 Mar 15;52(6):1622-7.
84. Tumor Protein p53 (TP53) Gene and Left Main Coronary Artery Disease. Kolovou V, etal., Angiology. 2018 Sep;69(8):730-735. doi: 10.1177/0003319718760075. Epub 2018 Feb 26.
85. Sunitinib Inhibits Breast Cancer Cell Proliferation by Inducing Apoptosis, Cell-cycle Arrest and DNA Repair While Inhibiting NF-κB Signaling Pathways. Korashy HM, etal., Anticancer Res. 2017 Sep;37(9):4899-4909. doi: 10.21873/anticanres.11899.
86. Acute ammonia neurotoxicity in vivo involves increase in cytoplasmic protein P53 without alterations in other markers of apoptosis. Kosenko E, etal., J Neurosci Res. 2007 Aug 15;85(11):2491-9.
87. Prognostic value of genetic alterations in children with first bone marrow relapse of childhood B-cell precursor acute lymphoblastic leukemia. Krentz S, etal., Leukemia. 2013 Feb;27(2):295-304. doi: 10.1038/leu.2012.155. Epub 2012 Jun 13.
88. Modes of p53 regulation. Kruse JP and Gu W, Cell. 2009 May 15;137(4):609-22. doi: 10.1016/j.cell.2009.04.050.
89. Glutamine supplementation prevents exercise-induced neutrophil apoptosis and reduces p38 MAPK and JNK phosphorylation and p53 and caspase 3 expression. Lagranha CJ, etal., Cell Biochem Funct. 2007 Sep-Oct;25(5):563-9.
90. Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma. Lapke N, etal., Oncotarget. 2016 Jul 12;7(28):44194-44210. doi: 10.18632/oncotarget.9925.
91. Species-specific regulation of alternative splicing in the C-terminal region of the p53 tumor suppressor gene. Laverdiere M, etal., Nucleic Acids Res 2000 Mar 15;28(6):1489-97.
92. The complexity of p53 stabilization and activation. Lavin MF and Gueven N, Cell Death Differ. 2006 Jun;13(6):941-50.
93. Cilostazol protects rat chondrocytes against nitric oxide-induced apoptosis in vitro and prevents cartilage destruction in a rat model of osteoarthritis. Lee SW, etal., Arthritis Rheum. 2008 Feb 29;58(3):790-800.
94. Ubiquitin-dependent degradation of p53 protein despite phosphorylation at its N terminus by acetaminophen. Lee YS, etal., J Pharmacol Exp Ther. 2006 Apr;317(1):202-8. Epub 2005 Dec 5.
95. Up-regulation of Smurf1 after spinal cord injury in adult rats. Li D, etal., J Mol Histol. 2013 Aug;44(4):381-90. doi: 10.1007/s10735-013-9499-2. Epub 2013 Apr 18.
96. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Li L, etal., Am J Physiol Cell Physiol 2001 Sep;281(3):C941-53.
97. Association of TP53 codon 72 genotype polymorphism and environmental factors with esophageal squamous cell carcinoma in the Mongolian population of the Chinese region of Inner Mongolia. Li M, etal., Oncol Lett. 2017 Aug;14(2):1484-1490. doi: 10.3892/ol.2017.6374. Epub 2017 Jun 13.
98. p53 initiates apoptosis by transcriptionally targeting the antiapoptotic protein ARC. Li YZ, etal., Mol Cell Biol. 2008 Jan;28(2):564-74. Epub 2007 Nov 12.
99. INHIBITION OF p53 BY PIFITHRIN-alpha REDUCES MYOCYTE APOPTOSIS AND LEUKOCYTE TRANSMIGRATION IN AGED RAT HEARTS FOLLOWING 24 HOURS OF REPERFUSION. Liu P, etal., Shock. 2008 Feb 28;.
100. Analysis of Tp53 codon 72 polymorphisms, Tp53 mutations, and HPV infection in cutaneous squamous cell carcinomas. Loeb KR, etal., PLoS One. 2012;7(4):e34422. doi: 10.1371/journal.pone.0034422. Epub 2012 Apr 24.
101. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Loghavi S, etal., Br J Haematol. 2015 Oct;171(1):91-9. doi: 10.1111/bjh.13529. Epub 2015 Jun 30.
102. Inhibition of protein phosphatase-1 is linked to phosphorylation of p53 and apoptosis. Long X, etal., Apoptosis 2002 Feb;7(1):31-9.
103. p53 inactivating mutations in Chinese nasopharyngeal carcinomas. Lung ML, etal., Cancer Lett. 1998 Nov 13;133(1):89-94.
104. Lack of association between MDM2 SNP309 and TP53 Arg72Pro polymorphisms with clinical outcomes in myelodysplastic syndrome. Machado-Neto JA, etal., Neoplasma. 2012;59(5):530-5. doi: 10.4149/neo_2012_068.
105. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas. Magrisso IJ, etal., Lab Invest. 1993 Dec;69(6):674-81.
106. Physical and functional interaction between WT1 and p53 proteins. Maheswaran S, etal., Proc Natl Acad Sci U S A. 1993 Jun 1;90(11):5100-4.
107. Frameshift mutational target gene analysis identifies similarities and differences in constitutional mismatch repair-deficiency and Lynch syndrome. Maletzki C, etal., Mol Carcinog. 2017 Jul;56(7):1753-1764. doi: 10.1002/mc.22632. Epub 2017 Mar 30.
108. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Malkin D, etal., Science 1990 Nov 30;250(4985):1233-8.
109. Protective role of fish oil (Maxepa) on early events of rat mammary carcinogenesis by modulation of DNA-protein crosslinks, cell proliferation and p53 expression. Manna S, etal., Cancer Cell Int. 2007 May 1;7:6.
110. Droplet digital PCR detects high rate of TP53 R249S mutants in cell-free DNA of middle African patients with hepatocellular carcinoma. Marchio A, etal., Clin Exp Med. 2018 Aug;18(3):421-431. doi: 10.1007/s10238-018-0502-9. Epub 2018 May 10.
111. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. Marino S, etal., Genes Dev 2000 Apr 15;14(8):994-1004.
112. Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors. Mastellaro MJ, etal., Cancer. 2017 Aug 15;123(16):3150-3158. doi: 10.1002/cncr.30703. Epub 2017 Apr 7.
113. Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. Mathupala SP, etal., J Biol Chem 1997 Sep 5;272(36):22776-80.
114. Creation and preliminary characterization of a Tp53 knockout rat. McCoy A, etal., Dis Model Mech. 2013 Jan;6(1):269-78. doi: 10.1242/dmm.009704. Epub 2012 Aug 23.
115. Nano-TiO2-induced apoptosis by oxidative stress-mediated DNA damage and activation of p53 in human embryonic kidney cells. Meena R, etal., Appl Biochem Biotechnol. 2012 Jun;167(4):791-808. doi: 10.1007/s12010-012-9699-3. Epub 2012 May 22.
116. Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast. Menezes MV, etal., Sao Paulo Med J. 2006 May 4;124(3):121-4.
117. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Menini S, etal., Diabetologia. 2007 Dec;50(12):2591-9. Epub 2007 Sep 28.
118. Combinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells. Mertens PR, etal., J Biol Chem 2002 Jul 12;277(28):24875-82.
119. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
120. The role of the TP53 gene during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Minicucci EM, etal., Exp Toxicol Pathol. 2011 Jul;63(5):483-9. doi: 10.1016/j.etp.2010.03.009. Epub 2010 Apr 10.
121. Hypomethylation of tumor suppressor genes in odontogenic myxoma. Moreira PR, etal., Braz Dent J. 2011;22(5):422-7.
122. p53 mutations in cancer. Muller PA and Vousden KH, Nat Cell Biol. 2013 Jan;15(1):2-8. doi: 10.1038/ncb2641.
123. Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway. Murali R, etal., Oncotarget. 2015 Nov 3;6(34):36041-52. doi: 10.18632/oncotarget.5936.
124. Loss of p53 cooperates with K-ras activation to induce glioma formation in a region-independent manner. Muñoz DM, etal., Glia. 2013 Nov;61(11):1862-72. doi: 10.1002/glia.22563. Epub 2013 Aug 30.
125. Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease. Nair VD Apoptosis. 2006 Jun;11(6):955-66.
126. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
127. Diagnostic utility of phosphatase and tensin homolog, beta-catenin, and p53 for endometrial carcinoma by thin-layer endometrial preparations. Norimatsu Y, etal., Cancer. 2008 Jun 25;114(3):155-64.
128. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD. Ogmundsdottir HM, etal., Eur J Oral Sci. 2002 Jun;110(3):192-8.
129. Mutational profiling of therapy-related myelodysplastic syndromes and acute myeloid leukemia by next generation sequencing, a comparison with de novo diseases. Ok CY, etal., Leuk Res. 2015 Mar;39(3):348-54. doi: 10.1016/j.leukres.2014.12.006. Epub 2014 Dec 20.
130. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Okazaki Y, etal., Oral Oncol. 2002 Sep;38(6):562-73.
131. MDM2 SNP309 and TP53 R72P associated with severe and febrile neutropenia in breast cancer patients treated with 5-FU/epirubicin/cyclophosphamide. Okishiro M, etal., Breast Cancer Res Treat. 2012 Apr;132(3):947-53. doi: 10.1007/s10549-011-1637-5. Epub 2011 Jun 25.
132. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma. Oliveira C, etal., J Cancer Res Clin Oncol. 2013 Jul;139(7):1199-206. doi: 10.1007/s00432-013-1430-4. Epub 2013 Apr 9.
133. OMIM Disease Annotation Pipeline OMIM Disease Annotation Pipeline
134. Suppressing activity of tributyrin on hepatocarcinogenesis is associated with inhibiting the p53-CRM1 interaction and changing the cellular compartmentalization of p53 protein. Ortega JF, etal., Oncotarget. 2016 Apr 26;7(17):24339-47. doi: 10.18632/oncotarget.8248.
135. p53 expression in various stages of 4-nitroquinoline 1-oxide induced carcinoma in the rat tongue. Osugi Y J Osaka Dent Univ. 1996 Dec;30(1-2):29-35.
136. UV-radiation-specific p53 mutation frequency in normal skin as a predictor of risk of basal cell carcinoma. Ouhtit A, etal., J Natl Cancer Inst. 1998 Apr 1;90(7):523-31.
137. MOXIBUSTION ALLEVIATES GASTRIC PRECANCEROUS LESIONS IN RATS BY PROMOTING CELL APOPTOSIS AND INHIBITING PROLIFERATION-RELATED ONCOGENES. Peng L, etal., Afr J Tradit Complement Altern Med. 2017 Jan 13;14(2):148-160. doi: 10.21010/ajtcam.v14i2.16. eCollection 2017.
138. Wood dust-related mutational profile of TP53 in intestinal-type sinonasal adenocarcinoma. Perez-Escuredo J, etal., Hum Pathol. 2012 Nov;43(11):1894-901. doi: 10.1016/j.humpath.2012.01.016. Epub 2012 May 8.
139. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
140. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
141. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
142. Apoptosis and inhibition of gap-junctional intercellular communication induced by LA-12, a novel hydrophobic platinum(IV) complex. Prochazka L, etal., Arch Biochem Biophys. 2007 Jun 1;462(1):54-61. Epub 2007 Apr 9.
143. Evidence that p53 behaves as a tumour suppressor gene in sporadic breast tumours. Prosser J, etal., Oncogene. 1990 Oct;5(10):1573-9.
144. Tumor suppressor p53 mediates apoptotic cell death triggered by cyclosporin A. Pyrzynska B, etal., J Biol Chem 2002 Apr 19;277(16):14102-8.
145. Effect of ischemic preconditioning on mitochondrial dysfunction and mitochondrial p53 translocation after transient global cerebral ischemia in rats. Racay P, etal., Neurochem Res. 2007 Nov;32(11):1823-32. Epub 2007 Jul 28.
146. Reactome: A Knowledgebase of Biological Processes Reactome
147. GOA pipeline RGD automated data pipeline
148. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
149. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
150. TP53 gene expression, codon 72 polymorphism and human papillomavirus DNA associated with pterygium. Rodrigues FW, etal., Genet Mol Res. 2008;7(4):1251-8.
151. p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis. Ruddell A, etal., Oncogene. 2008 May 15;27(22):3145-55. Epub 2007 Dec 3.
152. Licochalcone B Ameliorates Liver Cancer via Targeting of Apoptotic Genes, DNA Repair Systems, and Cell Cycle Control. Sadek K, etal., Iran J Pharm Res. 2020 Fall;19(4):372-386. doi: 10.22037/ijpr.2020.1101292.
153. Combinatorial control of the bradykinin B2 receptor promoter by p53, CREB, KLF-4, and CBP: implications for terminal nephron differentiation. Saifudeen Z, etal., Am J Physiol Renal Physiol. 2005 May;288(5):F899-909. Epub 2005 Jan 4.
154. Somatic mutations of signaling genes in non-small-cell lung cancer. Sanders HR and Albitar M, Cancer Genet Cytogenet. 2010 Nov;203(1):7-15.
155. Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer. Sano D, etal., Clin Cancer Res. 2011 Nov 1;17(21):6658-70. doi: 10.1158/1078-0432.CCR-11-0046. Epub 2011 Sep 8.
156. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women. Shabnaz S, etal., Tumour Biol. 2016 Jun;37(6):7229-37. doi: 10.1007/s13277-015-4612-7. Epub 2015 Dec 14.
157. Involvement of caspases and their upstream regulators in myocardial apoptosis in a rat model of selenium deficiency-induced dilated cardiomyopathy. Shan H, etal., J Trace Elem Med Biol. 2015;31:85-91. doi: 10.1016/j.jtemb.2015.03.005. Epub 2015 Apr 16.
158. TP53 deletions but not trisomy 12 are adverse in B-cell lymphoproliferative disorders. Shaw GR and Kronberger DL, Cancer Genet Cytogenet. 2000 Jun;119(2):146-54.
159. Effect of human umbilical cord blood derived CD34+ hematopoietic stem cell on the expression of Wnt4 and P53 genes in a rat model of hepatocellular carcinoma. Sherif RN, etal., Tissue Cell. 2018 Feb;50:125-132. doi: 10.1016/j.tice.2018.01.002. Epub 2018 Jan 8.
160. Janus Kinase 2 (JAK2) Dissociates Hepatosteatosis from Hepatocellular Carcinoma in Mice. Shi SY, etal., J Biol Chem. 2017 Mar 3;292(9):3789-3799. doi: 10.1074/jbc.M116.752519. Epub 2017 Jan 18.
161. Hindlimb unloading increases muscle content of cytosolic but not nuclear Id2 and p53 proteins in young adult and aged rats. Siu PM, etal., J Appl Physiol. 2006 Mar;100(3):907-16. Epub 2005 Nov 10.
162. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Sivaraman L, etal., Proc Natl Acad Sci U S A 2001 Oct 23;98(22):12379-84.
163. Connection between p53 gene Bam HI RFLP polymorphism with the volume of brain infarction in patients with carotid atherothrombotic ischemic stroke. Skvortsova VI, etal., Restor Neurol Neurosci. 2004;22(2):81-5.
164. Nucleotide sequence of a cDNA encoding the rat p53 nuclear oncoprotein. Soussi T, etal., Nucleic Acids Res 1988 Dec 9;16(23):11384.
165. Niacin deficiency alters p53 expression and impairs etoposide-induced cell cycle arrest and apoptosis in rat bone marrow cells. Spronck JC, etal., Nutr Cancer. 2007;57(1):88-99.
166. Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK. Storozhuk Y, etal., Br J Cancer. 2013 May 28;108(10):2021-32. doi: 10.1038/bjc.2013.187. Epub 2013 Apr 30.
167. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
168. p53 reaction to apoptosis induced by hydroxyapatite nanoparticles in rat macrophages. Sun J and Ding T, J Biomed Mater Res A. 2008 Mar 11;.
169. [Expression level of p53 in Tumor Tissue of Patients with Acute Leukemia and Its Clinical Significance]. Sun LT and Xiao WL, Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Oct;23(5):1240-4. doi: 10.7534/j.issn.1009-2137.2015.05.004.
170. IFN-gamma promotes apoptosis of the uterus and placenta in pregnant rat and human cytotrophoblast cells. Sun QH, etal., J Interferon Cytokine Res. 2007 Jul;27(7):567-78.
171. Mutation spectrum of TP53 gene predicts clinicopathological features and survival of gastric cancer. Tahara T, etal., Oncotarget. 2016 Jul 5;7(27):42252-60. doi: 10.18632/oncotarget.9770.
172. Next-Generation Sequencing Revealed TP53 Mutations to Be Malignant Marker for Intraductal Papillary Mucinous Neoplasms That Could Be Detected Using Pancreatic Juice. Takano S, etal., Pancreas. 2017 Nov/Dec;46(10):1281-1287. doi: 10.1097/MPA.0000000000000931.
173. Age-dependent upregulation of p53 and cytochrome c release and susceptibility to apoptosis in skeletal muscle fiber of aged rats: role of carnitine and lipoic acid. Tamilselvan J, etal., Free Radic Biol Med. 2007 Dec 15;43(12):1656-69. Epub 2007 Sep 14.
174. Mutant ubiquitin found in Alzheimer's disease causes neuritic beading of mitochondria in association with neuronal degeneration. Tan Z, etal., Cell Death Differ. 2007 Oct;14(10):1721-32. Epub 2007 Jun 15.
175. Clinical significance of p21(WAF1/CIP1) and p53 expression in serous cystadenocarcinoma of the ovary. Terauchi F, etal., Oncol Rep. 2005 Aug;14(2):363-8.
176. A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Tsai RY and McKay RD, Genes Dev 2002 Dec 1;16(23):2991-3003.
177. Functional inactivation but not structural mutation of p53 causes liver cancer. Ueda H, etal., Nat Genet 1995 Jan;9(1):41-7.
178. Diabetes alters expression of p53 and c-myc in different stages of oral oncogenesis. Vairaktaris E, etal., Anticancer Res. 2007 May-Jun;27(3B):1465-73.
179. Homozygous and heterozygous p53 knockout rats develop metastasizing sarcomas with high frequency. van Boxtel R, etal., Am J Pathol. 2011 Oct;179(4):1616-22. doi: 10.1016/j.ajpath.2011.06.036. Epub 2011 Aug 18.
180. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis. Varun BR, etal., J Investig Clin Dent. 2013 Jun 18. doi: 10.1111/jicd.12038.
181. A phase II study of ENMD-2076 in advanced soft tissue sarcoma (STS). Veitch Z, etal., Sci Rep. 2019 May 14;9(1):7390. doi: 10.1038/s41598-019-43222-6.
182. MDM2 rs2279744 and TP53 rs1042522 polymorphisms associated with etoposide- and cisplatin-induced grade III/IV neutropenia in Chinese extensive-stage small-cell lung cancer patients. Wang X, etal., Oncol Res Treat. 2014;37(4):176-80. doi: 10.1159/000360785. Epub 2014 Mar 20.
183. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. Wassmann S, etal., J Mol Cell Cardiol. 2007 Sep;43(3):301-7. Epub 2007 Jun 16.
184. Differentially expressed pro- and anti-apoptogenic genes in response to benzene exposure: Immunohistochemical localization of p53, Bag, Bad, Bax, Bcl-2, and Bcl-w in lung epithelia. Weaver CV and Liu SP, Exp Toxicol Pathol. 2008 Mar;59(5):265-72. Epub 2008 Feb 21.
185. Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance. Wei W, etal., Med Sci Monit. 2015 Oct 6;21:3016-22. doi: 10.12659/MSM.894640.
186. p53 polymorphisms: cancer implications. Whibley C, etal., Nat Rev Cancer. 2009 Feb;9(2):95-107.
187. The physical association of multiple molecular chaperone proteins with mutant p53 is altered by geldanamycin, an hsp90-binding agent. Whitesell L, etal., Mol Cell Biol. 1998 Mar;18(3):1517-24.
188. Activation of the p53-p21(Cip1) pathway is required for CDK2 activation and S-phase entry in primary rat hepatocytes. Wierod L, etal., Oncogene. 2007 Nov 19;.
189. The p53 codon 72 PRO/PRO genotype may be associated with initial central visual field defects in caucasians with primary open angle glaucoma. Wiggs JL, etal., PLoS One. 2012;7(9):e45613. doi: 10.1371/journal.pone.0045613. Epub 2012 Sep 26.
190. The tumor suppressor gene Trp53 protects the mouse lens against posterior subcapsular cataracts and the BMP receptor Acvr1 acts as a tumor suppressor in the lens. Wiley LA, etal., Dis Model Mech. 2011 Jul;4(4):484-95. doi: 10.1242/dmm.006593. Epub 2011 Apr 18.
191. Intense p53 staining is a valuable prognostic indicator for poor prognosis in medulloblastoma/central nervous system primitive neuroectodermal tumors. Woodburn RT, etal., J Neurooncol. 2001 Mar;52(1):57-62.
192. [Expression and significance of P53 and P21 in nasal NK/T-cell lymphoma]. Xu G, etal., Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 Jan;41(1):132-6.
193. Mutations in Tp53 gene sequences from lung tumors in rats that inhaled plutonium dioxide. Yamada Y and Oghiso Y, Radiat Res. 1999 Dec;152(6 Suppl):S107-9.
194. CELF1/p53 axis: a sustained antiproliferative signal leading to villus atrophy under total parenteral nutrition. Yan JK, etal., FASEB J. 2019 Mar;33(3):3378-3391. doi: 10.1096/fj.201801695R. Epub 2018 Dec 4.
195. Post-traumatic administration of the p53 inactivator pifithrin-α oxygen analogue reduces hippocampal neuronal loss and improves cognitive deficits after experimental traumatic brain injury. Yang LY, etal., Neurobiol Dis. 2016 Dec;96:216-226. doi: 10.1016/j.nbd.2016.08.012. Epub 2016 Aug 20.
196. Silencing of long non-coding RNA H19 downregulates CTCF to protect against atherosclerosis by upregulating PKD1 expression in ApoE knockout mice. Yang Y, etal., Aging (Albany NY). 2019 Nov 22;11(22):10016-10030. doi: 10.18632/aging.102388. Epub 2019 Nov 22.
197. TP53 inactivation and expression of methylation-associated proteins in gastric adenocarcinoma with enteroblastic differentiation. Yatagai N, etal., Virchows Arch. 2019 Mar;474(3):315-324. doi: 10.1007/s00428-018-2508-9. Epub 2018 Dec 15.
198. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-kappaB, COX-1, and COX-2. Yeoh AS, etal., Mol Cancer Ther. 2007 Aug;6(8):2319-27.
199. Neonatal bronchopulmonary dysplasia increases neuronal apoptosis in the hippocampus through the HIF-1alpha and p53 pathways. Yin R, etal., Respir Physiol Neurobiol. 2016 Jan;220:81-7. doi: 10.1016/j.resp.2015.09.011. Epub 2015 Sep 30.
200. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast. Yonemori K, etal., Pathol Res Pract. 2006;202(10):705-12. Epub 2006 Aug 2.
201. TP53 haplotype-based analysis and incidence of post-angioplasty restenosis. Zee RY, etal., Hum Genet. 2004 Mar;114(4):386-90. Epub 2004 Jan 22.
202. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. Zhang G, etal., J Ethnopharmacol. 2008 Feb 12;115(3):441-8. Epub 2007 Oct 25.
203. Hyperbaric Oxygen Attenuates Apoptosis and Decreases Inflammation in an Ischemic Wound Model. Zhang Q, etal., J Invest Dermatol. 2008 Mar 13;.
204. p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer. Zhang Z, etal., Mol Cancer Res. 2006 Jun;4(6):401-10.
205. Retinoic acid downregulates microRNAs to induce abnormal development of spinal cord in spina bifida rat model. Zhao JJ, etal., Childs Nerv Syst. 2008 Apr;24(4):485-92. Epub 2007 Oct 26.
206. Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes. Zhu Y, etal., Onkologie. 2008 Feb;31(1-2):37-41. Epub 2008 Jan 22.
207. Polyamine depletion induces nucleophosmin modulating stability and transcriptional activity of p53 in intestinal epithelial cells. Zou T, etal., Am J Physiol Cell Physiol. 2005 Sep;289(3):C686-96. Epub 2005 May 4.
208. Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1. Öner MG, etal., Gastroenterology. 2018 Dec;155(6):1868-1882. doi: 10.1053/j.gastro.2018.08.011. Epub 2018 Aug 10.
Additional References at PubMed
PMID:2144364   PMID:7587074   PMID:7663514   PMID:7677753   PMID:7720704   PMID:7824276   PMID:7958916   PMID:8058315   PMID:8183576   PMID:8183579   PMID:8612582   PMID:8663025  
PMID:8788039   PMID:8875929   PMID:8986812   PMID:9024662   PMID:9054499   PMID:9098922   PMID:9194565   PMID:9288110   PMID:9425892   PMID:9529249   PMID:9578398   PMID:9608530  
PMID:10065150   PMID:10205143   PMID:10360174   PMID:10415337   PMID:10518217   PMID:10562313   PMID:10567591   PMID:10591652   PMID:10591653   PMID:10597287   PMID:10666337   PMID:10710310  
PMID:10716720   PMID:10805805   PMID:10815637   PMID:10837489   PMID:10876243   PMID:10894779   PMID:10911993   PMID:10962037   PMID:10973261   PMID:11080164   PMID:11092819   PMID:11150333  
PMID:11246230   PMID:11546806   PMID:11672523   PMID:11748221   PMID:11781842   PMID:11790307   PMID:11799106   PMID:11861836   PMID:11884608   PMID:11900485   PMID:11923872   PMID:11958430  
PMID:11983168   PMID:12006491   PMID:12080348   PMID:12135983   PMID:12143041   PMID:12172011   PMID:12215673   PMID:12379483   PMID:12503078   PMID:12506145   PMID:12524542   PMID:12534344  
PMID:12538352   PMID:12549819   PMID:12654005   PMID:12667443   PMID:12730672   PMID:12835324   PMID:12837246   PMID:12850271   PMID:12869365   PMID:12878730   PMID:12915590   PMID:12952892  
PMID:14514686   PMID:14576152   PMID:14654789   PMID:14685795   PMID:14695767   PMID:14729462   PMID:14739302   PMID:14744935   PMID:14962081   PMID:14963330   PMID:14985081   PMID:15002037  
PMID:15033826   PMID:15044383   PMID:15053879   PMID:15122989   PMID:15149599   PMID:15199126   PMID:15219885   PMID:15314173   PMID:15315938   PMID:15340061   PMID:15358771   PMID:15364958  
PMID:15383658   PMID:15483136   PMID:15485914   PMID:15532030   PMID:15565177   PMID:15577914   PMID:15629713   PMID:15657445   PMID:15705871   PMID:15710329   PMID:15735665   PMID:15735701  
PMID:15782130   PMID:15829407   PMID:15898111   PMID:15922606   PMID:15983387   PMID:15990448   PMID:16000635   PMID:16005638   PMID:16044147   PMID:16061649   PMID:16098148   PMID:16107883  
PMID:16118209   PMID:16131611   PMID:16183742   PMID:16199867   PMID:16204796   PMID:16207712   PMID:16213212   PMID:16286009   PMID:16291740   PMID:16322561   PMID:16328969   PMID:16357222  
PMID:16363065   PMID:16392041   PMID:16407291   PMID:16427076   PMID:16461914   PMID:16479015   PMID:16491117   PMID:16507995   PMID:16571598   PMID:16614397   PMID:16690610   PMID:16702401  
PMID:16729028   PMID:16760664   PMID:16777961   PMID:16817227   PMID:16870742   PMID:16914427   PMID:16937528   PMID:17000767   PMID:17053789   PMID:17060322   PMID:17068116   PMID:17073802  
PMID:17116431   PMID:17121812   PMID:17130840   PMID:17145718   PMID:17146433   PMID:17200209   PMID:17210642   PMID:17234627   PMID:17245430   PMID:17310983   PMID:17320900   PMID:17325035  
PMID:17332504   PMID:17368433   PMID:17403783   PMID:17418105   PMID:17431217   PMID:17442733   PMID:17470788   PMID:17476307   PMID:17515607   PMID:17540029   PMID:17546582   PMID:17556661  
PMID:17591690   PMID:17594519   PMID:17599062   PMID:17612295   PMID:17620598   PMID:17805299   PMID:17881359   PMID:17912366   PMID:17938203   PMID:17996705   PMID:18057955   PMID:18086682  
PMID:18087040   PMID:18162465   PMID:18181021   PMID:18212064   PMID:18279588   PMID:18332125   PMID:18382127   PMID:18404539   PMID:18408766   PMID:18497077   PMID:18516675   PMID:18545656  
PMID:18549481   PMID:18555008   PMID:18614532   PMID:18625840   PMID:18649423   PMID:18656278   PMID:18691572   PMID:18703674   PMID:18724031   PMID:18753141   PMID:18756595   PMID:18775851  
PMID:18809582   PMID:18924150   PMID:18945670   PMID:18948218   PMID:19011621   PMID:19052818   PMID:19059678   PMID:19111121   PMID:19136059   PMID:19160485   PMID:19168033   PMID:19170070  
PMID:19234109   PMID:19305162   PMID:19330797   PMID:19339993   PMID:19349302   PMID:19411634   PMID:19458132   PMID:19505873   PMID:19513548   PMID:19576024   PMID:19618124   PMID:19667193  
PMID:19684617   PMID:19749791   PMID:19765618   PMID:19797907   PMID:19819240   PMID:19910580   PMID:19950214   PMID:19951988   PMID:20004160   PMID:20032585   PMID:20062521   PMID:20094059  
PMID:20096447   PMID:20113312   PMID:20124405   PMID:20159469   PMID:20160708   PMID:20173098   PMID:20332243   PMID:20364130   PMID:20368352   PMID:20378837   PMID:20413784   PMID:20424134  
PMID:20434500   PMID:20483005   PMID:20506231   PMID:20515733   PMID:20530960   PMID:20546595   PMID:20562916   PMID:20569441   PMID:20594980   PMID:20650967   PMID:20696760   PMID:20703075  
PMID:20720180   PMID:20725088   PMID:20810912   PMID:20818388   PMID:20855262   PMID:20935145   PMID:20935146   PMID:20959462   PMID:20972911   PMID:21159655   PMID:21164280   PMID:21178074  
PMID:21178334   PMID:21181359   PMID:21187408   PMID:21189548   PMID:21300779   PMID:21317932   PMID:21336310   PMID:21376104   PMID:21471221   PMID:21498419   PMID:21522129   PMID:21522133  
PMID:21546003   PMID:21656845   PMID:21712954   PMID:21748659   PMID:21908547   PMID:21912060   PMID:21959983   PMID:21965303   PMID:21988832   PMID:22011578   PMID:22023760   PMID:22044588  
PMID:22046440   PMID:22073357   PMID:22145321   PMID:22154326   PMID:22262176   PMID:22294442   PMID:22296365   PMID:22319579   PMID:22330834   PMID:22362889   PMID:22405968   PMID:22420318  
PMID:22499991   PMID:22505033   PMID:22514887   PMID:22515118   PMID:22521434   PMID:22574148   PMID:22578566   PMID:22653443   PMID:22726440   PMID:22737085   PMID:22738191   PMID:22763759  
PMID:22783376   PMID:22791818   PMID:22801079   PMID:22806321   PMID:22821713   PMID:22833673   PMID:22869143   PMID:22884071   PMID:22897442   PMID:22904064   PMID:22954396   PMID:22972749  
PMID:22991965   PMID:23027130   PMID:23051735   PMID:23059819   PMID:23069657   PMID:23174211   PMID:23277542   PMID:23352991   PMID:23402272   PMID:23538210   PMID:23568954   PMID:23588680  
PMID:23608382   PMID:23625637   PMID:23629966   PMID:23631263   PMID:23648705   PMID:23657598   PMID:23678040   PMID:23714159   PMID:23714208   PMID:23810908   PMID:23935987   PMID:23948959  
PMID:24013501   PMID:24014029   PMID:24043441   PMID:24051492   PMID:24101517   PMID:24189031   PMID:24223793   PMID:24240685   PMID:24269759   PMID:24289924   PMID:24312187   PMID:24356969  
PMID:24421392   PMID:24550317   PMID:24567336   PMID:24652652   PMID:24670206   PMID:24704558   PMID:24763879   PMID:24986327   PMID:25236576   PMID:25247799   PMID:25356872   PMID:25402006  
PMID:25417702   PMID:25470941   PMID:25506925   PMID:25547174   PMID:25609649   PMID:25655048   PMID:25767724   PMID:25773675   PMID:25791630   PMID:25811670   PMID:25890299   PMID:25912675  
PMID:25936182   PMID:26100857   PMID:26111627   PMID:26158450   PMID:26302161   PMID:26384650   PMID:26400065   PMID:26426258   PMID:26456506   PMID:26497030   PMID:26553132   PMID:26571802  
PMID:26675978   PMID:26677001   PMID:26714124   PMID:26792455   PMID:26968221   PMID:27008853   PMID:27046449   PMID:27221738   PMID:27258785   PMID:27387128   PMID:27584794   PMID:27665784  
PMID:27703600   PMID:27878231   PMID:27881147   PMID:28002632   PMID:28093932   PMID:28100501   PMID:28131915   PMID:28220272   PMID:28220578   PMID:28237798   PMID:28358926   PMID:28411026  
PMID:28414026   PMID:28486954   PMID:28634073   PMID:28678856   PMID:28798142   PMID:28800961   PMID:28842590   PMID:28885617   PMID:29039595   PMID:29048679   PMID:29199862   PMID:29286111  
PMID:29333769   PMID:29344658   PMID:29498408   PMID:29504377   PMID:29620173   PMID:29978915   PMID:30089260   PMID:30146126   PMID:30488170   PMID:30502252   PMID:30511343   PMID:30592279  
PMID:30887692   PMID:30949500   PMID:30968966   PMID:30998966   PMID:31032366   PMID:31420372   PMID:31432116   PMID:31638262   PMID:31787253   PMID:31973811   PMID:32000560   PMID:32026570  
PMID:32314164   PMID:32329863   PMID:32344470   PMID:32462563   PMID:32770526   PMID:32810137   PMID:33028080   PMID:33159115   PMID:33336750   PMID:33638320   PMID:34064070   PMID:34318554  
PMID:34709507   PMID:35201648   PMID:35275303   PMID:35421805   PMID:35538032   PMID:35542987   PMID:36044972   PMID:36282438   PMID:36841153   PMID:37495427   PMID:37580538   PMID:37935918  
PMID:38168028   PMID:38288820   PMID:39094671  


Genomics

Comparative Map Data
Tp53
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81054,798,871 - 54,810,300 (+)NCBIGRCr8
mRatBN7.21054,300,070 - 54,311,525 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1054,300,048 - 54,311,524 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1058,962,496 - 58,973,951 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01058,451,039 - 58,462,496 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01053,958,739 - 53,970,151 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01056,186,299 - 56,198,449 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1056,187,020 - 56,198,449 (+)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01055,932,658 - 55,944,087 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41056,399,721 - 56,411,150 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11056,413,290 - 56,424,751 (+)NCBI
Celera1053,454,375 - 53,465,803 (+)NCBICelera
Cytogenetic Map10q24NCBI
TP53
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38177,668,421 - 7,687,490 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl177,661,779 - 7,687,546 (-)EnsemblGRCh38hg38GRCh38
GRCh37177,571,739 - 7,590,808 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36177,512,445 - 7,531,642 (-)NCBINCBI36Build 36hg18NCBI36
Build 34177,512,463 - 7,531,642NCBI
Celera177,598,099 - 7,617,224 (-)NCBICelera
Cytogenetic Map17p13.1NCBI
HuRef177,465,169 - 7,484,283 (-)NCBIHuRef
CHM1_1177,580,866 - 7,600,003 (-)NCBICHM1_1
T2T-CHM13v2.0177,572,544 - 7,591,594 (-)NCBIT2T-CHM13v2.0
Trp53
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm391169,471,174 - 69,482,699 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1169,471,185 - 69,482,699 (+)EnsemblGRCm39 Ensembl
GRCm381169,580,348 - 69,591,873 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1169,580,359 - 69,591,873 (+)EnsemblGRCm38mm10GRCm38
MGSCv371169,393,861 - 69,405,375 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361169,396,176 - 69,408,066 (+)NCBIMGSCv36mm8
Celera1176,543,319 - 76,554,788 (+)NCBICelera
Cytogenetic Map11B3NCBI
cM Map1142.83NCBI
Tp53
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554679,252,130 - 9,255,928 (+)EnsemblChiLan1.0
ChiLan1.0NW_0049554679,241,391 - 9,256,716 (+)NCBIChiLan1.0ChiLan1.0
TP53
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21915,262,550 - 15,280,917 (-)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11717,217,636 - 17,246,939 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0177,699,449 - 7,717,812 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1177,687,132 - 7,706,120 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl177,684,922 - 7,706,120 (-)Ensemblpanpan1.1panPan2
TP53
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1532,561,406 - 32,565,149 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl532,560,598 - 32,574,109 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha532,699,559 - 32,713,071 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0532,665,395 - 32,678,721 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl532,665,394 - 32,678,755 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1532,633,092 - 32,646,601 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0532,589,339 - 32,602,824 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0532,768,467 - 32,781,775 (-)NCBIUU_Cfam_GSD_1.0
Tp53
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440560247,445,372 - 47,461,208 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936595919,428 - 925,425 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_004936595919,807 - 935,367 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
TP53
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1252,939,644 - 52,953,818 (-)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11252,939,643 - 52,953,786 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21255,220,545 - 55,234,668 (+)NCBISscrofa10.2Sscrofa10.2susScr3
Pig Cytomap12q12-q14NCBI
TP53
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1167,047,686 - 7,065,567 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl167,045,146 - 7,066,223 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366605914,343,255 - 14,361,299 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Tp53
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_00462478610,263,518 - 10,271,218 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462478610,266,316 - 10,282,664 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in Tp53
52 total Variants
miRNA Target Status (No longer updated)

Confirmed Target Of
miRNA GeneMature miRNAMethod NameResult TypeData TypeSupport TypePMID
Mir30arno-miR-30a-5pMirtarbaseexternal_infoWestern blot//Luciferase reporter assayFunctional MTI20062521

Predicted Target Of
Summary Value
Count of predictions:340
Count of miRNA genes:177
Interacting mature miRNAs:198
Transcripts:ENSRNOT00000046490
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCr8)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
61441Btemp1Thermal response to stress QTL 14body temperature trait (VT:0005535)core body temperature (CMO:0001036)103539245763642539Rat
1549846Scl47Serum cholesterol level QTL 473.6blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)105057470795574707Rat
9589136Insul27Insulin level QTL 2710.460.001blood insulin amount (VT:0001560)plasma insulin level (CMO:0000342)101147401056474010Rat
152025229Scl83Serum cholesterol level QTL 834.33blood cholesterol amount (VT:0000180)103571058068663659Rat
1578779Tcas10Tongue tumor susceptibility QTL 103.12tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950)103129743976297439Rat
152025227Bw195Body weight QTL 1955.73body mass (VT:0001259)104698969968663659Rat
631564Apr3Acute phase response QTL 33.9blood interleukin-6 amount (VT:0008595)plasma interleukin-6 level (CMO:0001927)101527595560275955Rat
1298069Bp168Blood pressure QTL 1685.5blood pressure trait (VT:0000183)systolic blood pressure (CMO:0000004)102652195798003205Rat
2293669Bmd33Bone mineral density QTL 334.50.0001femur strength trait (VT:0010010)femoral neck polar moment of inertia (CMO:0001670)104944455181709989Rat
152025224Bw193Body weight QTL 1936.47body mass (VT:0001259)105166340575085664Rat
631552Vetf2Vascular elastic tissue fragility QTL 24.50.0002aorta elastic tissue integrity trait (VT:0010556)artery internal elastic lamina non-tumorous lesion count (CMO:0001913)104114263386142633Rat
631554Bp133Blood pressure QTL 1330.005arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)1074336463851208Rat
631557Bp136Blood pressure QTL 1360.003arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)103063205375632053Rat
61325Aia5Adjuvant induced arthritis QTL 50.01joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023444813104060283Rat
1298078Stresp5Stress response QTL 52.990.00025blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)1042045676104670812Rat
2293679Bmd30Bone mineral density QTL 303.50.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)104944455181709989Rat
1578762Toxo1Toxoplasma gondii resistance QTL 1brain integrity trait (VT:0010579)percentage of study population displaying Toxoplasma gondii brain cysts at a point in time (CMO:0002028)105220003059378278Rat
2298544Neuinf9Neuroinflammation QTL 94.6nervous system integrity trait (VT:0010566)spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126)10580199062146030Rat
70164Bw21Body weight QTL 214.360.00005body mass (VT:0001259)body weight (CMO:0000012)105379749498952626Rat
61463Bp12Blood pressure QTL 126.30.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)104133325886333258Rat
8694173Bw149Body weight QTL 1494.380.001body mass (VT:0001259)body weight gain (CMO:0000420)104444169989441699Rat
2300218Hpcl2Hepatic cholesterol level QTL 2liver cholesterol amount (VT:0010498)liver cholesterol level (CMO:0001597)104502965095600334Rat
1554317Bmd4Bone mineral density QTL 49.40.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)101981604299406971Rat
70171Cari1Carrageenan-induced inflammation QTL 14.90.0005hypodermis integrity trait (VT:0010550)inflammatory exudate volume (CMO:0001429)1053797385107211142Rat
1598852Anxrr19Anxiety related response QTL 195.07body movement coordination trait (VT:0005424)number of rearing movements in an experimental apparatus (CMO:0001752)101816784163167841Rat
1581497Esta1Estrogen-induced thymic atrophy QTL 1thymus mass (VT:0004954)thymus wet weight (CMO:0000855)102132980561345413Rat
724527Bp148Blood pressure QTL 1480.0001arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)102845313673453136Rat
1358897Stresp6Stress response QTL 64.170.022blood norepinephrine amount (VT:0005663)plasma norepinephrine level (CMO:0001010)103539226764155584Rat
1331762Rf40Renal function QTL 403.873kidney blood vessel physiology trait (VT:0100012)absolute change in renal vascular resistance (CMO:0001900)102929950464155584Rat
2300171Bmd58Bone mineral density QTL 584.90.0001lumbar vertebra mineral mass (VT:0010511)volumetric bone mineral density (CMO:0001553)102694462871944628Rat
61354Pia10Pristane induced arthritis QTL 100.01joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023444813104060283Rat
2301967Cm73Cardiac mass QTL 734.55heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)101448701189062041Rat
2303118Mamtr7Mammary tumor resistance QTL 70.003mammary gland integrity trait (VT:0010552)mammary tumor growth rate (CMO:0000344)109658275104670812Rat
70188BpQTLcluster1Blood pressure QTL cluster 14.864arterial blood pressure trait (VT:2000000)pulse pressure (CMO:0000292)14232313287323132Rat
9590310Scort19Serum corticosterone level QTL 196.30.001blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)101147401056474010Rat
9589030Epfw9Epididymal fat weight QTL 919.240.001epididymal fat pad mass (VT:0010421)epididymal fat pad weight to body weight ratio (CMO:0000658)104444169989441699Rat
10402859Bp381Blood pressure QTL 3810.002arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)102760646872606468Rat
2316949Gluco60Glucose level QTL 603.7blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)1014487011107057807Rat
2293652Bmd22Bone mineral density QTL 224.90.0001femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)104944455181709989Rat
70198BpQTLcluster9Blood pressure QTL cluster 92.94arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)104232313287323132Rat
1359017Hrtrt21Heart rate QTL 212.4heart pumping trait (VT:2000009)heart rate (CMO:0000002)105177294096772940Rat
2306787Ean3Experimental allergic neuritis QTL 33.1nervous system integrity trait (VT:0010566)body weight loss (CMO:0001399)105379738566979128Rat
6893352Bw100Body weight QTL 1000.330.6body mass (VT:0001259)body weight (CMO:0000012)11590666560906665Rat
724556Pur2Proteinuria QTL 25.5urine protein amount (VT:0005160)urine protein level (CMO:0000591)102242750090627625Rat
8662860Vetf10Vascular elastic tissue fragility QTL 10artery integrity trait (VT:0010639)number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562)10615418273453136Rat
61387Bp1Blood pressure QTL 15.1arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)1051770177107211142Rat
1354585Eae18aExperimental allergic encephalomyelitis QTL 18a7.50.0004nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis severity score (CMO:0001419)105379738558445852Rat
70223Bp57Blood pressure QTL 575arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)10180676123Rat
1354587Kidm21Kidney mass QTL 213.3kidney mass (VT:0002707)right kidney wet weight (CMO:0000082)101502851360430477Rat
6893350Bw99Body weight QTL 990.870.16body mass (VT:0001259)body weight (CMO:0000012)11590666560906665Rat
2317043Aia7Adjuvant induced arthritis QTL 73.82joint integrity trait (VT:0010548)left rear ankle joint diameter (CMO:0002149)103756507982565079Rat
70224Eae3Experimental allergic encephalomyelitis QTL 34.1nervous system integrity trait (VT:0010566)experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046)102652195761345413Rat
2317042Aia20Adjuvant induced arthritis QTL 203.38joint integrity trait (VT:0010548)right rear ankle joint diameter (CMO:0002150)103756507982565079Rat
1331791Cm31Cardiac mass QTL 313.84606heart mass (VT:0007028)heart wet weight (CMO:0000069)1029299504107211142Rat
2313087Bmd80Bone mineral density QTL 803.20.0001tibia mineral mass (VT:1000283)total volumetric bone mineral density (CMO:0001728)101960648364606483Rat
70364Bp72Blood pressure QTL 72arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)105112110096121100Rat
631530Tls3T-lymphoma susceptibility QTL 300.0001thymus integrity trait (VT:0010555)percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911)105177461295600334Rat
631535Cm51Cardiac mass QTL 513heart mass (VT:0007028)calculated heart weight (CMO:0000073)105178628291669536Rat
1576319Cia29Collagen induced arthritis QTL 29joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)103397392178973921Rat
8552805Bw145Body weight QTL 1452.2body mass (VT:0001259)change in body weight to body weight ratio (CMO:0002216)104194452678307017Rat
631267Cia20Collagen induced arthritis QTL 203.2joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1023444813104060283Rat
2293705Bmd25Bone mineral density QTL 257.10.0001femur mineral mass (VT:0010011)compact volumetric bone mineral density (CMO:0001730)104944455181709989Rat
1576308Schws1Schwannoma susceptibility QTL 10.0041nervous system integrity trait (VT:0010566)percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017)1040035094102359817Rat
631269Cia22Collagen induced arthritis QTL 228.9joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1040035094104060283Rat
631268Cia21Collagen induced arthritis QTL 213.1joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1014487011104060283Rat
9590268Scort13Serum corticosterone level QTL 133.260.001blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)101147401056474010Rat
7207811Bmd90Bone mineral density QTL 905.2femur size trait (VT:1000369)femoral neck cross-sectional area (CMO:0001697)104944455181709989Rat
1576311Pia26Pristane induced arthritis QTL 26joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)103122402675632053Rat
631270Cia23Collagen induced arthritis QTL 233.9joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)1040035094104060283Rat
7411614Foco18Food consumption QTL 180.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)104444169989441699Rat
631547Bp87Blood pressure QTL 874.5arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)104736947092369470Rat
61427Cia16Collagen induced arthritis QTL 163.2joint integrity trait (VT:0010548)joint inflammation composite score (CMO:0000919)10635789696121100Rat
6893342Cm78Cardiac mass QTL 780.10.88heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)104287676679813922Rat
2292441Bp308Blood pressure QTL 308arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)102760646872606468Rat
2313055Bw96Body weight QTL 963.60.0001body mass (VT:0001259)body weight (CMO:0000012)101960648364606483Rat
631542Bp82Blood pressure QTL 826.8arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)102652195798952741Rat

Markers in Region
RH128204  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21054,311,066 - 54,311,282 (+)MAPPERmRatBN7.2
Rnor_6.01056,197,991 - 56,198,206NCBIRnor6.0
Rnor_5.01055,943,629 - 55,943,844UniSTSRnor5.0
RGSC_v3.41056,410,692 - 56,410,907UniSTSRGSC3.4
Celera1053,465,345 - 53,465,560UniSTS
Cytogenetic Map10q24UniSTS
X00876  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21054,311,363 - 54,311,441 (+)MAPPERmRatBN7.2
mRatBN7.21880,956,863 - 80,956,942 (+)MAPPERmRatBN7.2
Rnor_6.01884,790,380 - 84,790,458NCBIRnor6.0
Rnor_6.01056,198,288 - 56,198,365NCBIRnor6.0
Rnor_5.01883,848,025 - 83,848,103UniSTSRnor5.0
Rnor_5.01055,943,926 - 55,944,003UniSTSRnor5.0
RGSC_v3.41056,410,989 - 56,411,066UniSTSRGSC3.4
RGSC_v3.41884,480,395 - 84,480,473UniSTSRGSC3.4
Celera1879,535,283 - 79,535,361UniSTS
Celera1053,465,642 - 53,465,719UniSTS
Cytogenetic Map10q24UniSTS
GDB:190076  
Rat AssemblyChrPosition (strand)SourceJBrowse
GRCr81054,807,589 - 54,807,975 (+)Marker Load Pipeline
mRatBN7.21054,308,814 - 54,309,200 (+)MAPPERmRatBN7.2
Rnor_6.0249,382,697 - 49,382,771NCBIRnor6.0
Rnor_6.01056,195,739 - 56,196,124NCBIRnor6.0
Rnor_5.01055,941,377 - 55,941,762UniSTSRnor5.0
Rnor_5.0267,753,862 - 67,753,936UniSTSRnor5.0
RGSC_v3.41056,408,440 - 56,408,825UniSTSRGSC3.4
Celera1053,463,093 - 53,463,478UniSTS
Cytogenetic Map10q24UniSTS
PMC316663P6  
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.21054,308,611 - 54,308,724 (+)MAPPERmRatBN7.2
Rnor_6.01056,195,536 - 56,195,648NCBIRnor6.0
Rnor_5.01055,941,174 - 55,941,286UniSTSRnor5.0
RGSC_v3.41056,408,237 - 56,408,349UniSTSRGSC3.4
Celera1053,462,890 - 53,463,002UniSTS
Cytogenetic Map10q24UniSTS
PMC316856P2  
Rat AssemblyChrPosition (strand)SourceJBrowse
GRCr81054,807,224 - 54,807,389 (+)Marker Load Pipeline
mRatBN7.21054,308,448 - 54,308,614 (+)MAPPERmRatBN7.2
Rnor_6.01056,195,373 - 56,195,538NCBIRnor6.0
Rnor_5.01055,941,011 - 55,941,176UniSTSRnor5.0
RGSC_v3.41056,408,074 - 56,408,239UniSTSRGSC3.4
Celera1053,462,727 - 53,462,892UniSTS
Cytogenetic Map10q24UniSTS


Related Rat Strains
The following Strains have been annotated to Tp53
F344-Tp53m1Kyo     STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc    


Genetic Models
This gene Tp53 is modified in the following models/strains:
SD-Tp53em3Mcwi     SD-Tp53em1Sage     STOCK-Tp53tm1(EGFP-Pac)Qly/Rrrc     F344-Tp53m1Kyo    


Expression

RNA-SEQ Expression

alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
nervous system
renal system
reproductive system
respiratory system
9 11 49 113 91 90 59 25 59 6 218 97 93 45 60 31

Sequence

Nucleotide Sequences
RefSeq Transcripts NM_001429993 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001429994 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001429995 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001429996 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_030989 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_008767773 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017597018 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_063268429 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_063268430 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AC136563 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF190270 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AF209191 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AH002222 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AH010014 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AY009504 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC081788 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC098663 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH473948 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CV126174 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  FQ232659 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  JAXUCZ010000010 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M26863 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  U90328 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X13058 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  Z93723 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Ensembl Acc Id: ENSRNOT00000046490   ⟹   ENSRNOP00000047840
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,300,052 - 54,311,521 (+)Ensembl
Rnor_6.0 Ensembl1056,187,020 - 56,198,448 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000080584   ⟹   ENSRNOP00000068796
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,306,942 - 54,309,573 (+)Ensembl
Rnor_6.0 Ensembl1056,193,856 - 56,198,031 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000083458   ⟹   ENSRNOP00000075724
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,300,052 - 54,310,666 (+)Ensembl
Rnor_6.0 Ensembl1056,193,866 - 56,198,000 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000085115   ⟹   ENSRNOP00000074031
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,300,753 - 54,311,523 (+)Ensembl
Rnor_6.0 Ensembl1056,187,679 - 56,198,449 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000091216   ⟹   ENSRNOP00000075683
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,306,942 - 54,311,524 (+)Ensembl
Rnor_6.0 Ensembl1056,193,866 - 56,198,000 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000102405   ⟹   ENSRNOP00000080907
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,300,048 - 54,311,519 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000104927   ⟹   ENSRNOP00000092831
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,305,746 - 54,311,524 (+)Ensembl
Ensembl Acc Id: ENSRNOT00000114382   ⟹   ENSRNOP00000089020
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl1054,305,746 - 54,310,954 (+)Ensembl
RefSeq Acc Id: NM_030989   ⟹   NP_112251
RefSeq Status: REVIEWED
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81054,798,871 - 54,810,300 (+)NCBI
mRatBN7.21054,300,096 - 54,311,525 (+)NCBI
Rnor_6.01056,187,020 - 56,198,449 (+)NCBI
Rnor_5.01055,932,658 - 55,944,087 (+)NCBI
RGSC_v3.41056,399,721 - 56,411,150 (+)RGD
Celera1053,454,375 - 53,465,803 (+)RGD
Sequence:
RefSeq Acc Id: XM_008767773   ⟹   XP_008765995
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81054,798,933 - 54,810,300 (+)NCBI
mRatBN7.21054,300,070 - 54,311,023 (+)NCBI
Rnor_6.01056,186,299 - 56,197,912 (+)NCBI
Sequence:
RefSeq Acc Id: XM_017597018   ⟹   XP_017452507
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81054,799,817 - 54,810,300 (+)NCBI
mRatBN7.21054,301,043 - 54,311,025 (+)NCBI
Rnor_6.01056,187,961 - 56,197,912 (+)NCBI
Sequence:
RefSeq Acc Id: XM_063268429   ⟹   XP_063124499
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81054,805,369 - 54,810,300 (+)NCBI
RefSeq Acc Id: XM_063268430   ⟹   XP_063124500
Type: CODING
Position:
Rat AssemblyChrPosition (strand)Source
GRCr81054,799,817 - 54,810,300 (+)NCBI
RefSeq Acc Id: NP_112251   ⟸   NM_030989
- UniProtKB: Q4KMA9 (UniProtKB/Swiss-Prot),   O09168 (UniProtKB/Swiss-Prot),   Q66HM0 (UniProtKB/Swiss-Prot),   P10361 (UniProtKB/Swiss-Prot),   A6HFR6 (UniProtKB/TrEMBL),   A0A8L2R913 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_008765995   ⟸   XM_008767773
- Peptide Label: isoform X2
- Sequence:
RefSeq Acc Id: XP_017452507   ⟸   XM_017597018
- Peptide Label: isoform X2
- Sequence:
Ensembl Acc Id: ENSRNOP00000068796   ⟸   ENSRNOT00000080584
Ensembl Acc Id: ENSRNOP00000074031   ⟸   ENSRNOT00000085115
Ensembl Acc Id: ENSRNOP00000075683   ⟸   ENSRNOT00000091216
Ensembl Acc Id: ENSRNOP00000075724   ⟸   ENSRNOT00000083458
Ensembl Acc Id: ENSRNOP00000047840   ⟸   ENSRNOT00000046490
Ensembl Acc Id: ENSRNOP00000080907   ⟸   ENSRNOT00000102405
Ensembl Acc Id: ENSRNOP00000092831   ⟸   ENSRNOT00000104927
Ensembl Acc Id: ENSRNOP00000089020   ⟸   ENSRNOT00000114382
RefSeq Acc Id: XP_063124500   ⟸   XM_063268430
- Peptide Label: isoform X1
RefSeq Acc Id: XP_063124499   ⟸   XM_063268429
- Peptide Label: isoform X1
Protein Domains
p53 DNA-binding   p53 tetramerisation   p53 transactivation

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P10361-F1-model_v2 AlphaFold P10361 1-391 view protein structure

Transcriptome

eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

Promoters
RGD ID:13697316
Promoter ID:EPDNEW_R7839
Type:initiation region
Name:Tp53_1
Description:tumor protein p53
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Rat AssemblyChrPosition (strand)Source
Rnor_6.01056,187,031 - 56,187,091EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:3889 AgrOrtholog
BioCyc Gene G2FUF-24540 BioCyc
Ensembl Genes ENSRNOG00000010756 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000046490 ENTREZGENE
  ENSRNOT00000046490.4 UniProtKB/Swiss-Prot
  ENSRNOT00000085115 ENTREZGENE
  ENSRNOT00000102405 ENTREZGENE
Gene3D-CATH 2.60.40.720 UniProtKB/Swiss-Prot
  4.10.170.10 UniProtKB/Swiss-Prot
  6.10.50.20 UniProtKB/Swiss-Prot
IMAGE_CLONE IMAGE:7193583 IMAGE-MGC_LOAD
  IMAGE:7384467 IMAGE-MGC_LOAD
InterPro p53-like_TF_DNA-bd UniProtKB/Swiss-Prot
  p53/RUNT-type_TF_DNA-bd_sf UniProtKB/Swiss-Prot
  p53_DNA-bd UniProtKB/Swiss-Prot
  p53_tetramer_sf UniProtKB/Swiss-Prot
  p53_tetrameristn UniProtKB/Swiss-Prot
  p53_transactivation_domain UniProtKB/Swiss-Prot
  p53_tumour_suppressor UniProtKB/Swiss-Prot
KEGG Report rno:24842 UniProtKB/Swiss-Prot
MGC_CLONE MGC:112612 IMAGE-MGC_LOAD
  MGC:93394 IMAGE-MGC_LOAD
NCBI Gene 24842 ENTREZGENE
PANTHER CELLULAR TUMOR ANTIGEN P53 UniProtKB/Swiss-Prot
  PTHR11447 UniProtKB/Swiss-Prot
Pfam P53 UniProtKB/Swiss-Prot
  P53_TAD UniProtKB/Swiss-Prot
  P53_tetramer UniProtKB/Swiss-Prot
PharmGKB TP53 RGD
PhenoGen Tp53 PhenoGen
PRINTS P53SUPPRESSR UniProtKB/Swiss-Prot
PROSITE P53 UniProtKB/Swiss-Prot
RatGTEx ENSRNOG00000010756 RatGTEx
Superfamily-SCOP SSF47719 UniProtKB/Swiss-Prot
  SSF49417 UniProtKB/Swiss-Prot
UniProt A0A0G2JTP9_RAT UniProtKB/TrEMBL
  A0A0G2KB75_RAT UniProtKB/TrEMBL
  A0A0G2KBB2_RAT UniProtKB/TrEMBL
  A0A8I5ZQW3_RAT UniProtKB/TrEMBL
  A0A8I6AAP4 ENTREZGENE, UniProtKB/TrEMBL
  A0A8I6AEF4_RAT UniProtKB/TrEMBL
  A0A8L2R913 ENTREZGENE, UniProtKB/TrEMBL
  A6HFR6 ENTREZGENE, UniProtKB/TrEMBL
  A6HFR8_RAT UniProtKB/TrEMBL
  O09168 ENTREZGENE
  P10361 ENTREZGENE, UniProtKB/Swiss-Prot
  Q4KMA9 ENTREZGENE
  Q66HM0 ENTREZGENE
  Q9EQL0_RAT UniProtKB/TrEMBL
UniProt Secondary O09168 UniProtKB/Swiss-Prot
  Q4KMA9 UniProtKB/Swiss-Prot
  Q66HM0 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2008-10-23 Tp53  tumor protein p53  Trp53  transformation related protein 53  Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2008-02-15 Trp53  transformation related protein 53  Tp53  tumor protein p53   Nomenclature updated to reflect human and mouse nomenclature 1299863 APPROVED
2003-04-09 Tp53  tumor protein p53     tumor protein p53 (Li-Fraumeni syndrome)  Name updated 629478 APPROVED
2002-06-10 Tp53  tumor protein p53 (Li-Fraumeni syndrome)      Name updated 70584 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_expression nuclear accumulation increased in estrogen- and progesterone-treated animals and in pregnant-involuted mammary glands 69666
gene_expression nuclear accumulation increased in estrogen- and progesterone-treated animals and in pregnant-involuted mammary glands 625510
gene_function transcription factor 70312
gene_mutations_overexpression mutations found in the DNA binding domain of the gene 625510
gene_process directly phosphorylates casein kinase I and II, double-stranded RNA-dependent protein kinase, c-Jun N-terminal kinase, and p38 MAP kinase 625510
gene_process maintains genome integrety 70312
gene_process maintains genome integrety 70313
gene_process plays a critical role in cell cycle arrest, DNA repair and apoptosis 70313
gene_protein 390 amino acid protein 70312
gene_regulation mRNA stability regulated by polyamines and Mdm2 in intestinal mucosal cells 70312
gene_regulation regulated by DNA damage or stress such as hypoxia or nucleotide deprivation 625510